data_1n9v_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1n9v _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 . . . . . 0 N--CA 1.481 1.095 0 N-CA-C 113.109 0.781 . . . . 1.9399999999999999 113.109 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 15.2 ttp180 -97.12 46.12 1.04 Allowed 'General case' 0 C--N 1.341 0.224 0 O-C-N 119.475 -2.015 . . . . 4.8499999999999996 109.748 -170.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 24.7 t -98.77 -27.8 3.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 123.983 0.913 . . . . 1.6299999999999999 108.787 176.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 60.0 t80 -152.86 84.17 1.22 Allowed 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 108.781 -0.822 . . . . 2.96 108.781 -175.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 35.8 mm -114.99 128.47 72.13 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 N-CA-C 106.215 -1.772 . . . . 1.6100000000000001 106.215 179.198 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 21.5 p80 -121.91 80.99 42.15 Favored Pre-proline 0 N--CA 1.445 -0.68 0 N-CA-C 107.302 -1.37 . . . . 0.41999999999999998 107.302 178.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -81.73 64.65 8.58 Favored 'Trans proline' 0 N--CA 1.451 -0.974 0 C-N-CA 122.211 1.941 . . . . 0.68000000000000005 108.244 179.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.023 0 C-N-CA 125.706 1.602 . . . . 6.6299999999999999 108.518 -178.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 . . . . . 0 N--CA 1.482 1.126 0 N-CA-C 112.945 0.72 . . . . 1.6100000000000001 112.945 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 2.2 ttt85 -98.17 47.78 1.0 Allowed 'General case' 0 C--O 1.225 -0.219 0 O-C-N 119.563 -1.961 . . . . 5.46 108.978 -170.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 24.1 t -100.34 -26.89 3.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 108.945 -0.761 . . . . 1.53 108.945 175.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 24.7 t80 -153.38 83.48 1.19 Allowed 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 108.644 -0.873 . . . . 2.9900000000000002 108.644 -175.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 31.7 mm -113.04 132.36 62.08 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 N-CA-C 105.977 -1.86 . . . . 1.7 105.977 178.037 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 16.3 p80 -124.65 72.66 61.11 Favored Pre-proline 0 N--CA 1.447 -0.6 0 N-CA-C 108.626 -0.879 . . . . 0.69999999999999996 108.626 179.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -72.48 90.58 0.79 Allowed 'Trans proline' 0 N--CA 1.45 -1.085 0 C-N-CA 121.762 1.641 . . . . 0.65000000000000002 108.709 -178.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 51.0 t80 . . . . . 0 C--O 1.252 1.206 0 CA-C-O 116.474 -1.726 . . . . 6.8799999999999999 107.65 170.829 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 . . . . . 0 N--CA 1.483 1.194 0 N-CA-C 112.838 0.681 . . . . 2.0099999999999998 112.838 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 34.3 ttm180 -97.43 47.18 1.03 Allowed 'General case' 0 C--O 1.225 -0.228 0 O-C-N 119.708 -1.87 . . . . 6.0800000000000001 109.216 -170.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 20.3 t -100.07 -27.11 3.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 108.614 -0.884 . . . . 1.6000000000000001 108.614 175.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 43.7 t80 -153.25 84.17 1.2 Allowed 'General case' 0 N--CA 1.441 -0.911 0 N-CA-C 108.713 -0.847 . . . . 2.9700000000000002 108.713 -176.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 29.0 mm -112.87 132.24 62.21 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 N-CA-C 105.59 -2.004 . . . . 1.3500000000000001 105.59 176.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 20.1 p80 -122.87 81.39 49.77 Favored Pre-proline 0 N--CA 1.444 -0.744 0 N-CA-C 107.215 -1.402 . . . . 0.40999999999999998 107.215 175.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -80.91 66.13 8.86 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 121.878 1.719 . . . . 0.64000000000000001 108.42 178.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.023 0 CA-C-O 116.742 -1.599 . . . . 6.6299999999999999 108.513 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 . . . . . 0 N--CA 1.482 1.14 0 N-CA-C 112.754 0.65 . . . . 1.8400000000000001 112.754 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 7.5 ttp85 -97.51 45.69 1.03 Allowed 'General case' 0 C--N 1.34 0.163 0 O-C-N 119.686 -1.884 . . . . 5.5499999999999998 109.364 -170.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 21.1 t -98.94 -27.72 3.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 108.896 -0.779 . . . . 1.76 108.896 176.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 38.4 t80 -152.98 83.35 1.21 Allowed 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 108.355 -0.979 . . . . 2.96 108.355 -175.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 29.0 mm -112.14 131.42 63.62 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 N-CA-C 105.871 -1.9 . . . . 1.6299999999999999 105.871 177.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 21.0 p80 -122.38 78.96 45.37 Favored Pre-proline 0 N--CA 1.444 -0.737 0 N-CA-C 107.551 -1.278 . . . . 0.44 107.551 176.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -79.69 70.11 7.65 Favored 'Trans proline' 0 N--CA 1.45 -1.029 0 C-N-CA 121.832 1.688 . . . . 0.58999999999999997 108.537 179.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.252 1.212 0 CA-C-O 116.93 -1.51 . . . . 6.3600000000000003 108.635 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 . . . . . 0 N--CA 1.483 1.177 0 N-CA-C 114.165 1.172 . . . . 1.9099999999999999 114.165 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 53.1 ttp180 -96.15 51.44 1.22 Allowed 'General case' 0 C--O 1.227 -0.117 0 O-C-N 119.724 -1.86 . . . . 4.7800000000000002 109.253 -171.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 38.8 t -102.81 -27.53 3.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 124.391 1.077 . . . . 1.5700000000000001 108.777 173.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 85.6 t80 -152.78 86.26 1.26 Allowed 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 108.893 -0.78 . . . . 4.2400000000000002 108.893 -174.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 40.6 mm -118.75 131.88 70.25 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 N-CA-C 106.031 -1.84 . . . . 1.48 106.031 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 13.5 p80 -125.71 73.15 69.26 Favored Pre-proline 0 N--CA 1.448 -0.527 0 N-CA-C 108.527 -0.916 . . . . 0.66000000000000003 108.527 -178.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -74.72 90.23 1.07 Allowed 'Trans proline' 0 N--CA 1.446 -1.296 0 C-N-CA 122.492 2.128 . . . . 0.67000000000000004 107.963 -177.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 37.7 t80 . . . . . 0 C--O 1.25 1.112 0 C-N-CA 125.661 1.584 . . . . 6.6799999999999997 108.361 172.766 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 . . . . . 0 N--CA 1.481 1.104 0 N-CA-C 113.08 0.77 . . . . 2.0699999999999998 113.08 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 22.2 ttm180 -99.21 48.54 0.95 Allowed 'General case' 0 C--N 1.341 0.203 0 O-C-N 119.602 -1.937 . . . . 6.0800000000000001 108.978 -170.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.1 t -100.01 -26.87 3.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 108.962 -0.755 . . . . 1.55 108.962 175.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 57.2 t80 -153.5 84.42 1.18 Allowed 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 108.717 -0.846 . . . . 4.2199999999999998 108.717 -174.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 36.1 mm -115.91 130.61 70.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 N-CA-C 106.2 -1.778 . . . . 1.7 106.2 179.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 14.8 p80 -124.69 73.44 62.61 Favored Pre-proline 0 N--CA 1.449 -0.499 0 N-CA-C 108.469 -0.937 . . . . 0.75 108.469 -178.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -74.7 88.49 1.19 Allowed 'Trans proline' 0 N--CA 1.447 -1.214 0 C-N-CA 122.171 1.914 . . . . 0.62 108.118 -178.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 23.4 t80 . . . . . 0 C--O 1.25 1.087 0 C-N-CA 125.688 1.595 . . . . 7.3799999999999999 108.002 171.717 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 . . . . . 0 N--CA 1.482 1.129 0 N-CA-C 112.85 0.685 . . . . 1.9099999999999999 112.85 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 24.9 ttp-105 -96.76 47.97 1.06 Allowed 'General case' 0 CA--C 1.521 -0.146 0 O-C-N 119.636 -1.915 . . . . 5.6799999999999997 109.178 -169.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 43.7 t -99.57 -26.82 3.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 108.709 -0.849 . . . . 1.8 108.709 173.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 33.0 t80 -152.8 85.07 1.23 Allowed 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 108.99 -0.745 . . . . 4.2800000000000002 108.99 -175.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 30.6 mm -113.77 135.55 53.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 N-CA-C 105.517 -2.031 . . . . 1.6799999999999999 105.517 177.131 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 12.5 p80 -126.58 73.4 74.29 Favored Pre-proline 0 N--CA 1.447 -0.612 0 N-CA-C 108.3 -1.0 . . . . 0.66000000000000003 108.3 179.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -73.67 91.08 0.9 Allowed 'Trans proline' 0 N--CA 1.448 -1.167 0 C-N-CA 122.292 1.995 . . . . 0.69999999999999996 108.16 -178.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 25.5 t80 . . . . . 0 C--O 1.249 1.066 0 C-N-CA 125.8 1.64 . . . . 7.8499999999999996 108.332 172.307 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 . . . . . 0 N--CA 1.48 1.062 0 N-CA-C 112.265 0.469 . . . . 1.8200000000000001 112.265 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 5.0 ttm180 -95.74 46.2 1.09 Allowed 'General case' 0 C--O 1.225 -0.207 0 O-C-N 119.68 -1.887 . . . . 5.7800000000000002 109.37 -171.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 22.3 t -99.98 -26.72 3.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 123.654 0.781 . . . . 1.77 108.927 176.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 48.0 t80 -152.64 85.86 1.26 Allowed 'General case' 0 N--CA 1.441 -0.911 0 N-CA-C 107.763 -1.199 . . . . 3.6400000000000001 107.763 -175.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 28.8 mm -114.73 130.74 68.62 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.502 0 N-CA-C 105.532 -2.025 . . . . 1.6200000000000001 105.532 177.128 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 21.9 p80 -122.35 81.33 45.74 Favored Pre-proline 0 N--CA 1.443 -0.807 0 N-CA-C 107.382 -1.34 . . . . 0.40000000000000002 107.382 175.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -80.94 65.0 8.96 Favored 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 121.796 1.664 . . . . 0.64000000000000001 108.518 178.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.254 1.306 0 C-N-CA 125.78 1.632 . . . . 6.2699999999999996 108.222 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 31.9 m-20 . . . . . 0 N--CA 1.479 0.998 0 N-CA-C 112.299 0.481 . . . . 1.8 112.299 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 41.1 ttp85 -93.76 44.01 1.12 Allowed 'General case' 0 C--N 1.341 0.215 0 O-C-N 119.788 -1.82 . . . . 5.0899999999999999 109.859 -171.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 22.2 t -101.29 -27.3 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 C-N-CA 124.153 0.981 . . . . 1.49 108.882 177.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 15.3 t80 -150.97 87.84 1.43 Allowed 'General case' 0 N--CA 1.443 -0.821 0 N-CA-C 107.915 -1.142 . . . . 2.9399999999999999 107.915 -176.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 37.6 mm -117.76 134.03 62.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 106.079 -1.822 . . . . 1.77 106.079 178.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 17.6 p80 -125.0 72.86 64.8 Favored Pre-proline 0 N--CA 1.45 -0.457 0 N-CA-C 108.667 -0.864 . . . . 0.46999999999999997 108.667 -178.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -74.09 90.82 0.96 Allowed 'Trans proline' 0 N--CA 1.447 -1.214 0 C-N-CA 122.426 2.084 . . . . 0.80000000000000004 108.11 -179.104 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 14.7 t80 . . . . . 0 C--O 1.249 1.049 0 C-N-CA 125.728 1.611 . . . . 8.0299999999999994 108.34 171.502 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 . . . . . 0 N--CA 1.48 1.025 0 CA-C-O 120.592 0.234 . . . . 1.6799999999999999 111.437 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 23.5 ttm180 -95.23 48.48 1.17 Allowed 'General case' 0 C--O 1.226 -0.162 0 O-C-N 119.715 -1.866 . . . . 6.04 108.874 -171.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 20.2 t -104.41 -26.12 3.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 C-N-CA 123.82 0.848 . . . . 1.71 109.015 175.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 18.4 t80 -151.67 86.87 1.34 Allowed 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 107.853 -1.166 . . . . 2.9300000000000002 107.853 -176.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 35.8 mm -116.67 130.71 71.07 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 N-CA-C 106.026 -1.842 . . . . 1.6100000000000001 106.026 178.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 21.5 p80 -121.15 81.65 36.81 Favored Pre-proline 0 N--CA 1.446 -0.67 0 N-CA-C 107.389 -1.337 . . . . 0.47999999999999998 107.389 178.035 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -81.56 64.4 8.63 Favored 'Trans proline' 0 N--CA 1.451 -0.992 0 C-N-CA 122.191 1.927 . . . . 0.57999999999999996 108.45 178.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.084 0 CA-C-O 116.681 -1.628 . . . . 6.3099999999999996 108.207 -179.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 . . . . . 0 N--CA 1.48 1.053 0 N-CA-C 111.728 0.27 . . . . 1.72 111.728 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 20.8 ttm180 -93.37 49.1 1.36 Allowed 'General case' 0 C--O 1.226 -0.183 0 O-C-N 119.776 -1.827 . . . . 5.8399999999999999 108.786 -173.302 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 23.9 t -104.93 -26.49 3.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 C-N-CA 123.911 0.884 . . . . 1.5600000000000001 109.124 174.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 20.4 t80 -151.03 87.55 1.41 Allowed 'General case' 0 N--CA 1.442 -0.861 0 N-CA-C 107.683 -1.229 . . . . 3.0 107.683 -176.352 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 36.7 mm -117.15 131.07 70.94 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 N-CA-C 105.922 -1.881 . . . . 1.6899999999999999 105.922 178.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 22.8 p80 -121.49 82.55 40.09 Favored Pre-proline 0 N--CA 1.444 -0.735 0 N-CA-C 107.285 -1.376 . . . . 0.55000000000000004 107.285 177.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -81.92 62.33 8.12 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 122.297 1.998 . . . . 0.58999999999999997 108.433 178.523 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.253 1.269 0 C-N-CA 126.01 1.724 . . . . 6.3600000000000003 108.042 -179.266 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 . . . . . 0 N--CA 1.479 1.005 0 N-CA-C 112.153 0.427 . . . . 1.6299999999999999 112.153 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 33.3 ttp180 -90.85 42.21 1.09 Allowed 'General case' 0 C--N 1.34 0.175 0 O-C-N 119.841 -1.787 . . . . 4.5700000000000003 110.44 -170.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 54.5 t -97.68 -28.88 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 C-N-CA 124.631 1.173 . . . . 1.76 108.978 174.279 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 22.1 t80 -148.48 88.75 1.65 Allowed 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 108.883 -0.784 . . . . 2.9300000000000002 108.883 -175.217 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 45.0 mm -120.44 135.69 59.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 N-CA-C 105.963 -1.866 . . . . 1.49 105.963 179.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 15.2 p80 -127.72 74.41 78.34 Favored Pre-proline 0 N--CA 1.449 -0.517 0 N-CA-C 108.364 -0.976 . . . . 0.47999999999999998 108.364 -177.027 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -75.08 88.17 1.27 Allowed 'Trans proline' 0 N--CA 1.447 -1.214 0 C-N-CA 122.828 2.352 . . . . 0.76000000000000001 108.397 -176.342 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 45.9 t80 . . . . . 0 C--O 1.249 1.045 0 C-N-CA 125.473 1.509 . . . . 7.0899999999999999 108.246 171.462 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 . . . . . 0 N--CA 1.48 1.044 0 N-CA-C 113.17 0.804 . . . . 1.5800000000000001 113.17 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 24.8 ttp180 -90.14 43.04 1.12 Allowed 'General case' 0 C--N 1.342 0.252 0 O-C-N 119.701 -1.875 . . . . 4.5300000000000002 110.663 -171.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 32.6 t -99.25 -28.11 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 C-N-CA 125.568 1.547 . . . . 1.7 108.626 175.503 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 40.9 t80 -150.2 89.75 1.61 Allowed 'General case' 0 N--CA 1.442 -0.869 0 N-CA-C 107.983 -1.118 . . . . 2.9399999999999999 107.983 -175.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 31.7 mm -119.24 138.28 50.43 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.459 0 N-CA-C 105.308 -2.108 . . . . 1.71 105.308 176.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 15.6 p80 -127.68 73.72 78.35 Favored Pre-proline 0 N--CA 1.446 -0.658 0 N-CA-C 108.309 -0.997 . . . . 0.54000000000000004 108.309 -179.17 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -72.63 94.75 0.78 Allowed 'Trans proline' 0 N--CA 1.447 -1.209 0 C-N-CA 121.646 1.564 . . . . 0.90000000000000002 108.771 -175.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 60.5 t80 . . . . . 0 C--O 1.253 1.28 0 CA-C-O 116.006 -1.95 . . . . 7.7400000000000002 106.751 171.313 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 . . . . . 0 N--CA 1.479 0.999 0 N-CA-C 112.204 0.446 . . . . 1.53 112.204 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 15.9 ttt180 -92.76 47.48 1.29 Allowed 'General case' 0 C--O 1.226 -0.173 0 O-C-N 119.958 -1.714 . . . . 4.6799999999999997 109.361 -172.437 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 23.5 t -103.59 -25.75 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 C-N-CA 123.992 0.917 . . . . 1.7 109.031 174.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 31.6 t80 -151.49 88.43 1.43 Allowed 'General case' 0 N--CA 1.44 -0.929 0 N-CA-C 107.854 -1.165 . . . . 3.8399999999999999 107.854 -175.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 39.2 mm -119.12 133.42 66.0 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 N-CA-C 105.982 -1.859 . . . . 1.4399999999999999 105.982 179.316 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 15.0 p80 -124.8 73.8 63.98 Favored Pre-proline 0 N--CA 1.45 -0.464 0 N-CA-C 108.513 -0.921 . . . . 0.46000000000000002 108.513 -178.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -74.29 89.72 1.05 Allowed 'Trans proline' 0 N--CA 1.447 -1.224 0 C-N-CA 122.415 2.076 . . . . 0.79000000000000004 108.144 -178.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 32.7 t80 . . . . . 0 C--O 1.249 1.031 0 C-N-CA 125.577 1.551 . . . . 6.8799999999999999 108.188 171.397 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 . . . . . 0 N--CA 1.477 0.924 0 CA-C-O 120.658 0.266 . . . . 1.5900000000000001 111.598 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 28.5 ttp180 -94.13 46.86 1.18 Allowed 'General case' 0 C--N 1.34 0.189 0 O-C-N 119.883 -1.761 . . . . 4.8300000000000001 109.48 -171.063 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 24.9 t -104.2 -27.2 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 C-N-CA 124.133 0.973 . . . . 1.54 109.171 176.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 24.6 t80 -150.29 87.5 1.46 Allowed 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 107.592 -1.262 . . . . 3.9100000000000001 107.592 -176.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 33.2 mm -116.56 131.94 67.67 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 N-CA-C 105.886 -1.894 . . . . 1.3899999999999999 105.886 177.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 23.3 p80 -121.58 81.96 40.27 Favored Pre-proline 0 N--CA 1.445 -0.696 0 N-CA-C 107.481 -1.303 . . . . 0.55000000000000004 107.481 176.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -81.53 60.64 7.75 Favored 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 122.121 1.88 . . . . 0.65000000000000002 108.995 179.256 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.248 0.986 0 C-N-CA 126.264 1.826 . . . . 6.1399999999999997 108.049 -177.227 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 . . . . . 0 N--CA 1.48 1.033 0 N-CA-C 111.608 0.225 . . . . 1.78 111.608 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 25.6 ttm180 -93.48 48.4 1.3 Allowed 'General case' 0 C--O 1.225 -0.19 0 O-C-N 119.835 -1.791 . . . . 5.9299999999999997 109.016 -172.552 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 25.6 t -104.56 -26.76 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 C-N-CA 123.841 0.856 . . . . 1.7 109.198 175.136 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 32.4 t80 -150.8 87.28 1.41 Allowed 'General case' 0 N--CA 1.441 -0.91 0 N-CA-C 107.101 -1.444 . . . . 3.0800000000000001 107.101 -176.106 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 26.9 mm -115.64 132.65 64.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 105.205 -2.146 . . . . 1.6599999999999999 105.205 176.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 23.0 p80 -121.36 85.36 42.4 Favored Pre-proline 0 N--CA 1.442 -0.851 0 N-CA-C 107.028 -1.471 . . . . 0.56000000000000005 107.028 174.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_endo -81.42 58.69 6.99 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 122.079 1.852 . . . . 0.64000000000000001 108.761 176.252 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.254 1.297 0 C-N-CA 126.202 1.801 . . . . 6.5700000000000003 107.711 -179.455 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 31.0 m-20 . . . . . 0 N--CA 1.479 1.014 0 N-CA-C 112.078 0.399 . . . . 1.53 112.078 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 3.2 ttp85 -92.82 44.65 1.16 Allowed 'General case' 0 C--N 1.339 0.124 0 O-C-N 119.897 -1.752 . . . . 5.4100000000000001 109.84 -171.066 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 24.2 t -101.89 -26.54 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 C-N-CA 123.917 0.887 . . . . 1.6899999999999999 108.939 176.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 27.9 t80 -150.99 87.48 1.41 Allowed 'General case' 0 N--CA 1.441 -0.911 0 N-CA-C 107.599 -1.26 . . . . 2.96 107.599 -176.272 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 27.9 mm -115.87 133.25 62.89 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.514 0 N-CA-C 105.422 -2.066 . . . . 1.71 105.422 176.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 21.0 p80 -121.67 83.2 41.87 Favored Pre-proline 0 N--CA 1.444 -0.743 0 N-CA-C 107.288 -1.375 . . . . 0.54000000000000004 107.288 175.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -81.47 61.92 8.19 Favored 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 122.015 1.81 . . . . 0.59999999999999998 108.748 178.044 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.065 0 C-N-CA 126.252 1.821 . . . . 6.3099999999999996 108.133 -178.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 . . . . . 0 N--CA 1.48 1.037 0 CA-C-O 120.597 0.237 . . . . 1.8200000000000001 111.53 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 57.2 ttt180 -93.46 46.89 1.21 Allowed 'General case' 0 C--O 1.226 -0.18 0 O-C-N 119.735 -1.853 . . . . 4.8600000000000003 109.078 -171.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 16.0 t -103.95 -26.81 3.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 C-N-CA 124.17 0.988 . . . . 1.6699999999999999 108.859 176.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -151.28 86.93 1.36 Allowed 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 107.415 -1.328 . . . . 3.0099999999999998 107.415 -176.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 28.2 mm -114.71 134.59 57.25 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.488 0 N-CA-C 105.423 -2.065 . . . . 1.3899999999999999 105.423 176.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 23.5 p80 -123.27 80.16 52.71 Favored Pre-proline 0 N--CA 1.444 -0.762 0 N-CA-C 107.564 -1.273 . . . . 0.55000000000000004 107.564 176.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -80.84 65.87 8.88 Favored 'Trans proline' 0 N--CA 1.452 -0.954 0 C-N-CA 121.944 1.762 . . . . 0.57999999999999996 108.98 -179.566 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.022 0 C-N-CA 126.066 1.746 . . . . 6.4000000000000004 108.22 -178.291 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.478 0.936 0 CA-C-O 120.708 0.29 . . . . 1.8300000000000001 111.337 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 41.8 ttp180 -94.61 45.57 1.12 Allowed 'General case' 0 C--N 1.341 0.198 0 O-C-N 119.727 -1.858 . . . . 4.8799999999999999 109.476 -170.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 22.6 t -103.05 -27.4 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 C-N-CA 124.106 0.963 . . . . 1.5 109.104 177.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 16.5 t80 -150.64 85.98 1.38 Allowed 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 107.356 -1.35 . . . . 3.8900000000000001 107.356 -176.208 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 27.7 mm -114.26 133.71 59.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 N-CA-C 105.62 -1.993 . . . . 1.6299999999999999 105.62 176.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 22.1 p80 -122.12 79.88 43.41 Favored Pre-proline 0 N--CA 1.444 -0.743 0 N-CA-C 107.765 -1.198 . . . . 0.5 107.765 176.126 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -79.4 69.73 7.8 Favored 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 121.861 1.707 . . . . 0.51000000000000001 108.571 178.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.011 0 CA-C-O 116.821 -1.562 . . . . 6.25 108.75 179.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 . . . . . 0 N--CA 1.479 1.016 0 N-CA-C 111.873 0.323 . . . . 1.6200000000000001 111.873 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 25.2 ttm180 -92.71 49.9 1.52 Allowed 'General case' 0 C--O 1.224 -0.259 0 O-C-N 119.842 -1.786 . . . . 5.9199999999999999 108.83 -173.243 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 42.9 t -103.89 -27.27 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 C-N-CA 123.876 0.87 . . . . 1.5700000000000001 109.112 172.302 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 15.7 t80 -150.07 87.06 1.45 Allowed 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 108.316 -0.994 . . . . 2.9100000000000001 108.316 -175.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 39.8 mm -117.38 130.7 71.87 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 N-CA-C 106.012 -1.847 . . . . 1.72 106.012 179.008 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 22.0 p80 -122.29 81.79 45.42 Favored Pre-proline 0 N--CA 1.446 -0.664 0 N-CA-C 107.249 -1.389 . . . . 0.48999999999999999 107.249 178.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -82.25 63.97 8.26 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 122.307 2.004 . . . . 0.58999999999999997 108.352 -179.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.254 1.302 0 C-N-CA 125.902 1.681 . . . . 6.29 108.208 -178.7 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 . . . . . 0 N--CA 1.481 1.092 0 N-CA-C 113.127 0.788 . . . . 0.0 113.127 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 20.6 ttp180 -92.33 42.5 1.1 Allowed 'General case' 0 C--N 1.34 0.193 0 O-C-N 119.618 -1.926 . . . . 0.0 110.463 -168.051 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 38.5 t -97.43 -28.01 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 C-N-CA 125.49 1.516 . . . . 0.0 108.64 175.234 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 31.2 t80 -148.98 86.03 1.49 Allowed 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 -177.371 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 27.7 mm -114.04 136.05 51.78 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.484 0 N-CA-C 105.45 -2.056 . . . . 0.0 105.45 174.611 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 18.0 p80 -124.77 77.1 65.14 Favored Pre-proline 0 N--CA 1.443 -0.776 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 176.606 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -74.77 86.39 1.39 Allowed 'Trans proline' 0 N--CA 1.45 -1.064 0 C-N-CA 121.612 1.541 . . . . 0.0 108.555 -175.634 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 2.7 t80 . . . . . 0 C--O 1.249 1.054 0 CA-C-O 117.405 -1.283 . . . . 0.0 107.751 177.433 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 . . . . . 0 N--CA 1.481 1.095 0 N-CA-C 113.109 0.781 . . . . 1.9399999999999999 113.109 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 15.2 ttp180 -97.12 46.12 1.04 Allowed 'General case' 0 C--N 1.341 0.224 0 O-C-N 119.475 -2.015 . . . . 4.8499999999999996 109.748 -170.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 24.7 t -98.77 -27.8 3.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 123.983 0.913 . . . . 1.6299999999999999 108.787 176.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 60.0 t80 -152.86 84.17 1.22 Allowed 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 108.781 -0.822 . . . . 2.96 108.781 -175.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 35.8 mm -114.99 128.47 72.13 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 N-CA-C 106.215 -1.772 . . . . 1.6100000000000001 106.215 179.198 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 21.5 p80 -121.91 80.99 42.15 Favored Pre-proline 0 N--CA 1.445 -0.68 0 N-CA-C 107.302 -1.37 . . . . 0.41999999999999998 107.302 178.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -81.73 64.65 8.58 Favored 'Trans proline' 0 N--CA 1.451 -0.974 0 C-N-CA 122.211 1.941 . . . . 0.68000000000000005 108.244 179.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.023 0 C-N-CA 125.706 1.602 . . . . 6.6299999999999999 108.518 -178.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 . . . . . 0 N--CA 1.482 1.126 0 N-CA-C 112.945 0.72 . . . . 1.6100000000000001 112.945 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 2.2 ttt85 -98.17 47.78 1.0 Allowed 'General case' 0 C--O 1.225 -0.219 0 O-C-N 119.563 -1.961 . . . . 5.46 108.978 -170.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 24.1 t -100.34 -26.89 3.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 108.945 -0.761 . . . . 1.53 108.945 175.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 24.7 t80 -153.38 83.48 1.19 Allowed 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 108.644 -0.873 . . . . 2.9900000000000002 108.644 -175.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 31.7 mm -113.04 132.36 62.08 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 N-CA-C 105.977 -1.86 . . . . 1.7 105.977 178.037 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 16.3 p80 -124.65 72.66 61.11 Favored Pre-proline 0 N--CA 1.447 -0.6 0 N-CA-C 108.626 -0.879 . . . . 0.69999999999999996 108.626 179.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -72.48 90.58 0.79 Allowed 'Trans proline' 0 N--CA 1.45 -1.085 0 C-N-CA 121.762 1.641 . . . . 0.65000000000000002 108.709 -178.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 51.0 t80 . . . . . 0 C--O 1.252 1.206 0 CA-C-O 116.474 -1.726 . . . . 6.8799999999999999 107.65 170.829 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 . . . . . 0 N--CA 1.483 1.194 0 N-CA-C 112.838 0.681 . . . . 2.0099999999999998 112.838 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 34.3 ttm180 -97.43 47.18 1.03 Allowed 'General case' 0 C--O 1.225 -0.228 0 O-C-N 119.708 -1.87 . . . . 6.0800000000000001 109.216 -170.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 20.3 t -100.07 -27.11 3.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 108.614 -0.884 . . . . 1.6000000000000001 108.614 175.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 43.7 t80 -153.25 84.17 1.2 Allowed 'General case' 0 N--CA 1.441 -0.911 0 N-CA-C 108.713 -0.847 . . . . 2.9700000000000002 108.713 -176.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 29.0 mm -112.87 132.24 62.21 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 N-CA-C 105.59 -2.004 . . . . 1.3500000000000001 105.59 176.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 20.1 p80 -122.87 81.39 49.77 Favored Pre-proline 0 N--CA 1.444 -0.744 0 N-CA-C 107.215 -1.402 . . . . 0.40999999999999998 107.215 175.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -80.91 66.13 8.86 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 121.878 1.719 . . . . 0.64000000000000001 108.42 178.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.023 0 CA-C-O 116.742 -1.599 . . . . 6.6299999999999999 108.513 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 . . . . . 0 N--CA 1.482 1.14 0 N-CA-C 112.754 0.65 . . . . 1.8400000000000001 112.754 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 7.5 ttp85 -97.51 45.69 1.03 Allowed 'General case' 0 C--N 1.34 0.163 0 O-C-N 119.686 -1.884 . . . . 5.5499999999999998 109.364 -170.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 21.1 t -98.94 -27.72 3.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 108.896 -0.779 . . . . 1.76 108.896 176.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 38.4 t80 -152.98 83.35 1.21 Allowed 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 108.355 -0.979 . . . . 2.96 108.355 -175.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 29.0 mm -112.14 131.42 63.62 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 N-CA-C 105.871 -1.9 . . . . 1.6299999999999999 105.871 177.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 21.0 p80 -122.38 78.96 45.37 Favored Pre-proline 0 N--CA 1.444 -0.737 0 N-CA-C 107.551 -1.278 . . . . 0.44 107.551 176.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -79.69 70.11 7.65 Favored 'Trans proline' 0 N--CA 1.45 -1.029 0 C-N-CA 121.832 1.688 . . . . 0.58999999999999997 108.537 179.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.252 1.212 0 CA-C-O 116.93 -1.51 . . . . 6.3600000000000003 108.635 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 . . . . . 0 N--CA 1.483 1.177 0 N-CA-C 114.165 1.172 . . . . 1.9099999999999999 114.165 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 53.1 ttp180 -96.15 51.44 1.22 Allowed 'General case' 0 C--O 1.227 -0.117 0 O-C-N 119.724 -1.86 . . . . 4.7800000000000002 109.253 -171.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 38.8 t -102.81 -27.53 3.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 124.391 1.077 . . . . 1.5700000000000001 108.777 173.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 85.6 t80 -152.78 86.26 1.26 Allowed 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 108.893 -0.78 . . . . 4.2400000000000002 108.893 -174.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 40.6 mm -118.75 131.88 70.25 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 N-CA-C 106.031 -1.84 . . . . 1.48 106.031 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 13.5 p80 -125.71 73.15 69.26 Favored Pre-proline 0 N--CA 1.448 -0.527 0 N-CA-C 108.527 -0.916 . . . . 0.66000000000000003 108.527 -178.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -74.72 90.23 1.07 Allowed 'Trans proline' 0 N--CA 1.446 -1.296 0 C-N-CA 122.492 2.128 . . . . 0.67000000000000004 107.963 -177.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 37.7 t80 . . . . . 0 C--O 1.25 1.112 0 C-N-CA 125.661 1.584 . . . . 6.6799999999999997 108.361 172.766 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 . . . . . 0 N--CA 1.481 1.104 0 N-CA-C 113.08 0.77 . . . . 2.0699999999999998 113.08 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 22.2 ttm180 -99.21 48.54 0.95 Allowed 'General case' 0 C--N 1.341 0.203 0 O-C-N 119.602 -1.937 . . . . 6.0800000000000001 108.978 -170.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.1 t -100.01 -26.87 3.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 108.962 -0.755 . . . . 1.55 108.962 175.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 57.2 t80 -153.5 84.42 1.18 Allowed 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 108.717 -0.846 . . . . 4.2199999999999998 108.717 -174.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 36.1 mm -115.91 130.61 70.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 N-CA-C 106.2 -1.778 . . . . 1.7 106.2 179.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 14.8 p80 -124.69 73.44 62.61 Favored Pre-proline 0 N--CA 1.449 -0.499 0 N-CA-C 108.469 -0.937 . . . . 0.75 108.469 -178.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -74.7 88.49 1.19 Allowed 'Trans proline' 0 N--CA 1.447 -1.214 0 C-N-CA 122.171 1.914 . . . . 0.62 108.118 -178.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 23.4 t80 . . . . . 0 C--O 1.25 1.087 0 C-N-CA 125.688 1.595 . . . . 7.3799999999999999 108.002 171.717 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 . . . . . 0 N--CA 1.482 1.129 0 N-CA-C 112.85 0.685 . . . . 1.9099999999999999 112.85 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 24.9 ttp-105 -96.76 47.97 1.06 Allowed 'General case' 0 CA--C 1.521 -0.146 0 O-C-N 119.636 -1.915 . . . . 5.6799999999999997 109.178 -169.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 43.7 t -99.57 -26.82 3.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 108.709 -0.849 . . . . 1.8 108.709 173.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 33.0 t80 -152.8 85.07 1.23 Allowed 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 108.99 -0.745 . . . . 4.2800000000000002 108.99 -175.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 30.6 mm -113.77 135.55 53.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 N-CA-C 105.517 -2.031 . . . . 1.6799999999999999 105.517 177.131 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 12.5 p80 -126.58 73.4 74.29 Favored Pre-proline 0 N--CA 1.447 -0.612 0 N-CA-C 108.3 -1.0 . . . . 0.66000000000000003 108.3 179.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -73.67 91.08 0.9 Allowed 'Trans proline' 0 N--CA 1.448 -1.167 0 C-N-CA 122.292 1.995 . . . . 0.69999999999999996 108.16 -178.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 25.5 t80 . . . . . 0 C--O 1.249 1.066 0 C-N-CA 125.8 1.64 . . . . 7.8499999999999996 108.332 172.307 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 . . . . . 0 N--CA 1.48 1.062 0 N-CA-C 112.265 0.469 . . . . 1.8200000000000001 112.265 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 5.0 ttm180 -95.74 46.2 1.09 Allowed 'General case' 0 C--O 1.225 -0.207 0 O-C-N 119.68 -1.887 . . . . 5.7800000000000002 109.37 -171.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 22.3 t -99.98 -26.72 3.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 123.654 0.781 . . . . 1.77 108.927 176.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 48.0 t80 -152.64 85.86 1.26 Allowed 'General case' 0 N--CA 1.441 -0.911 0 N-CA-C 107.763 -1.199 . . . . 3.6400000000000001 107.763 -175.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 28.8 mm -114.73 130.74 68.62 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.502 0 N-CA-C 105.532 -2.025 . . . . 1.6200000000000001 105.532 177.128 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 21.9 p80 -122.35 81.33 45.74 Favored Pre-proline 0 N--CA 1.443 -0.807 0 N-CA-C 107.382 -1.34 . . . . 0.40000000000000002 107.382 175.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -80.94 65.0 8.96 Favored 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 121.796 1.664 . . . . 0.64000000000000001 108.518 178.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.254 1.306 0 C-N-CA 125.78 1.632 . . . . 6.2699999999999996 108.222 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 31.9 m-20 . . . . . 0 N--CA 1.479 0.998 0 N-CA-C 112.299 0.481 . . . . 1.8 112.299 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 41.1 ttp85 -93.76 44.01 1.12 Allowed 'General case' 0 C--N 1.341 0.215 0 O-C-N 119.788 -1.82 . . . . 5.0899999999999999 109.859 -171.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 22.2 t -101.29 -27.3 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 C-N-CA 124.153 0.981 . . . . 1.49 108.882 177.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 15.3 t80 -150.97 87.84 1.43 Allowed 'General case' 0 N--CA 1.443 -0.821 0 N-CA-C 107.915 -1.142 . . . . 2.9399999999999999 107.915 -176.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 37.6 mm -117.76 134.03 62.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 106.079 -1.822 . . . . 1.77 106.079 178.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 17.6 p80 -125.0 72.86 64.8 Favored Pre-proline 0 N--CA 1.45 -0.457 0 N-CA-C 108.667 -0.864 . . . . 0.46999999999999997 108.667 -178.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -74.09 90.82 0.96 Allowed 'Trans proline' 0 N--CA 1.447 -1.214 0 C-N-CA 122.426 2.084 . . . . 0.80000000000000004 108.11 -179.104 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 14.7 t80 . . . . . 0 C--O 1.249 1.049 0 C-N-CA 125.728 1.611 . . . . 8.0299999999999994 108.34 171.502 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 . . . . . 0 N--CA 1.48 1.025 0 CA-C-O 120.592 0.234 . . . . 1.6799999999999999 111.437 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 23.5 ttm180 -95.23 48.48 1.17 Allowed 'General case' 0 C--O 1.226 -0.162 0 O-C-N 119.715 -1.866 . . . . 6.04 108.874 -171.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 20.2 t -104.41 -26.12 3.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 C-N-CA 123.82 0.848 . . . . 1.71 109.015 175.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 18.4 t80 -151.67 86.87 1.34 Allowed 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 107.853 -1.166 . . . . 2.9300000000000002 107.853 -176.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 35.8 mm -116.67 130.71 71.07 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 N-CA-C 106.026 -1.842 . . . . 1.6100000000000001 106.026 178.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 21.5 p80 -121.15 81.65 36.81 Favored Pre-proline 0 N--CA 1.446 -0.67 0 N-CA-C 107.389 -1.337 . . . . 0.47999999999999998 107.389 178.035 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -81.56 64.4 8.63 Favored 'Trans proline' 0 N--CA 1.451 -0.992 0 C-N-CA 122.191 1.927 . . . . 0.57999999999999996 108.45 178.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.084 0 CA-C-O 116.681 -1.628 . . . . 6.3099999999999996 108.207 -179.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 . . . . . 0 N--CA 1.48 1.053 0 N-CA-C 111.728 0.27 . . . . 1.72 111.728 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 20.8 ttm180 -93.37 49.1 1.36 Allowed 'General case' 0 C--O 1.226 -0.183 0 O-C-N 119.776 -1.827 . . . . 5.8399999999999999 108.786 -173.302 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 23.9 t -104.93 -26.49 3.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 C-N-CA 123.911 0.884 . . . . 1.5600000000000001 109.124 174.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 20.4 t80 -151.03 87.55 1.41 Allowed 'General case' 0 N--CA 1.442 -0.861 0 N-CA-C 107.683 -1.229 . . . . 3.0 107.683 -176.352 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 36.7 mm -117.15 131.07 70.94 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 N-CA-C 105.922 -1.881 . . . . 1.6899999999999999 105.922 178.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 22.8 p80 -121.49 82.55 40.09 Favored Pre-proline 0 N--CA 1.444 -0.735 0 N-CA-C 107.285 -1.376 . . . . 0.55000000000000004 107.285 177.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -81.92 62.33 8.12 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 122.297 1.998 . . . . 0.58999999999999997 108.433 178.523 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.253 1.269 0 C-N-CA 126.01 1.724 . . . . 6.3600000000000003 108.042 -179.266 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 . . . . . 0 N--CA 1.479 1.005 0 N-CA-C 112.153 0.427 . . . . 1.6299999999999999 112.153 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 33.3 ttp180 -90.85 42.21 1.09 Allowed 'General case' 0 C--N 1.34 0.175 0 O-C-N 119.841 -1.787 . . . . 4.5700000000000003 110.44 -170.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 54.5 t -97.68 -28.88 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 C-N-CA 124.631 1.173 . . . . 1.76 108.978 174.279 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 22.1 t80 -148.48 88.75 1.65 Allowed 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 108.883 -0.784 . . . . 2.9300000000000002 108.883 -175.217 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 45.0 mm -120.44 135.69 59.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 N-CA-C 105.963 -1.866 . . . . 1.49 105.963 179.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 15.2 p80 -127.72 74.41 78.34 Favored Pre-proline 0 N--CA 1.449 -0.517 0 N-CA-C 108.364 -0.976 . . . . 0.47999999999999998 108.364 -177.027 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -75.08 88.17 1.27 Allowed 'Trans proline' 0 N--CA 1.447 -1.214 0 C-N-CA 122.828 2.352 . . . . 0.76000000000000001 108.397 -176.342 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 45.9 t80 . . . . . 0 C--O 1.249 1.045 0 C-N-CA 125.473 1.509 . . . . 7.0899999999999999 108.246 171.462 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 . . . . . 0 N--CA 1.48 1.044 0 N-CA-C 113.17 0.804 . . . . 1.5800000000000001 113.17 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 24.8 ttp180 -90.14 43.04 1.12 Allowed 'General case' 0 C--N 1.342 0.252 0 O-C-N 119.701 -1.875 . . . . 4.5300000000000002 110.663 -171.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 32.6 t -99.25 -28.11 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 C-N-CA 125.568 1.547 . . . . 1.7 108.626 175.503 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 40.9 t80 -150.2 89.75 1.61 Allowed 'General case' 0 N--CA 1.442 -0.869 0 N-CA-C 107.983 -1.118 . . . . 2.9399999999999999 107.983 -175.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 31.7 mm -119.24 138.28 50.43 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.459 0 N-CA-C 105.308 -2.108 . . . . 1.71 105.308 176.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 15.6 p80 -127.68 73.72 78.35 Favored Pre-proline 0 N--CA 1.446 -0.658 0 N-CA-C 108.309 -0.997 . . . . 0.54000000000000004 108.309 -179.17 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -72.63 94.75 0.78 Allowed 'Trans proline' 0 N--CA 1.447 -1.209 0 C-N-CA 121.646 1.564 . . . . 0.90000000000000002 108.771 -175.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 60.5 t80 . . . . . 0 C--O 1.253 1.28 0 CA-C-O 116.006 -1.95 . . . . 7.7400000000000002 106.751 171.313 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 . . . . . 0 N--CA 1.479 0.999 0 N-CA-C 112.204 0.446 . . . . 1.53 112.204 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 15.9 ttt180 -92.76 47.48 1.29 Allowed 'General case' 0 C--O 1.226 -0.173 0 O-C-N 119.958 -1.714 . . . . 4.6799999999999997 109.361 -172.437 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 23.5 t -103.59 -25.75 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 C-N-CA 123.992 0.917 . . . . 1.7 109.031 174.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 31.6 t80 -151.49 88.43 1.43 Allowed 'General case' 0 N--CA 1.44 -0.929 0 N-CA-C 107.854 -1.165 . . . . 3.8399999999999999 107.854 -175.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 39.2 mm -119.12 133.42 66.0 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 N-CA-C 105.982 -1.859 . . . . 1.4399999999999999 105.982 179.316 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 15.0 p80 -124.8 73.8 63.98 Favored Pre-proline 0 N--CA 1.45 -0.464 0 N-CA-C 108.513 -0.921 . . . . 0.46000000000000002 108.513 -178.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -74.29 89.72 1.05 Allowed 'Trans proline' 0 N--CA 1.447 -1.224 0 C-N-CA 122.415 2.076 . . . . 0.79000000000000004 108.144 -178.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 32.7 t80 . . . . . 0 C--O 1.249 1.031 0 C-N-CA 125.577 1.551 . . . . 6.8799999999999999 108.188 171.397 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 . . . . . 0 N--CA 1.477 0.924 0 CA-C-O 120.658 0.266 . . . . 1.5900000000000001 111.598 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 28.5 ttp180 -94.13 46.86 1.18 Allowed 'General case' 0 C--N 1.34 0.189 0 O-C-N 119.883 -1.761 . . . . 4.8300000000000001 109.48 -171.063 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 24.9 t -104.2 -27.2 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 C-N-CA 124.133 0.973 . . . . 1.54 109.171 176.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 24.6 t80 -150.29 87.5 1.46 Allowed 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 107.592 -1.262 . . . . 3.9100000000000001 107.592 -176.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 33.2 mm -116.56 131.94 67.67 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 N-CA-C 105.886 -1.894 . . . . 1.3899999999999999 105.886 177.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 23.3 p80 -121.58 81.96 40.27 Favored Pre-proline 0 N--CA 1.445 -0.696 0 N-CA-C 107.481 -1.303 . . . . 0.55000000000000004 107.481 176.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -81.53 60.64 7.75 Favored 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 122.121 1.88 . . . . 0.65000000000000002 108.995 179.256 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.248 0.986 0 C-N-CA 126.264 1.826 . . . . 6.1399999999999997 108.049 -177.227 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 . . . . . 0 N--CA 1.48 1.033 0 N-CA-C 111.608 0.225 . . . . 1.78 111.608 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 25.6 ttm180 -93.48 48.4 1.3 Allowed 'General case' 0 C--O 1.225 -0.19 0 O-C-N 119.835 -1.791 . . . . 5.9299999999999997 109.016 -172.552 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 25.6 t -104.56 -26.76 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 C-N-CA 123.841 0.856 . . . . 1.7 109.198 175.136 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 32.4 t80 -150.8 87.28 1.41 Allowed 'General case' 0 N--CA 1.441 -0.91 0 N-CA-C 107.101 -1.444 . . . . 3.0800000000000001 107.101 -176.106 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 26.9 mm -115.64 132.65 64.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 105.205 -2.146 . . . . 1.6599999999999999 105.205 176.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 23.0 p80 -121.36 85.36 42.4 Favored Pre-proline 0 N--CA 1.442 -0.851 0 N-CA-C 107.028 -1.471 . . . . 0.56000000000000005 107.028 174.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_endo -81.42 58.69 6.99 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 122.079 1.852 . . . . 0.64000000000000001 108.761 176.252 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.254 1.297 0 C-N-CA 126.202 1.801 . . . . 6.5700000000000003 107.711 -179.455 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 31.0 m-20 . . . . . 0 N--CA 1.479 1.014 0 N-CA-C 112.078 0.399 . . . . 1.53 112.078 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 3.2 ttp85 -92.82 44.65 1.16 Allowed 'General case' 0 C--N 1.339 0.124 0 O-C-N 119.897 -1.752 . . . . 5.4100000000000001 109.84 -171.066 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 24.2 t -101.89 -26.54 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 C-N-CA 123.917 0.887 . . . . 1.6899999999999999 108.939 176.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 27.9 t80 -150.99 87.48 1.41 Allowed 'General case' 0 N--CA 1.441 -0.911 0 N-CA-C 107.599 -1.26 . . . . 2.96 107.599 -176.272 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 27.9 mm -115.87 133.25 62.89 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.514 0 N-CA-C 105.422 -2.066 . . . . 1.71 105.422 176.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 21.0 p80 -121.67 83.2 41.87 Favored Pre-proline 0 N--CA 1.444 -0.743 0 N-CA-C 107.288 -1.375 . . . . 0.54000000000000004 107.288 175.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -81.47 61.92 8.19 Favored 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 122.015 1.81 . . . . 0.59999999999999998 108.748 178.044 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.065 0 C-N-CA 126.252 1.821 . . . . 6.3099999999999996 108.133 -178.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 . . . . . 0 N--CA 1.48 1.037 0 CA-C-O 120.597 0.237 . . . . 1.8200000000000001 111.53 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 57.2 ttt180 -93.46 46.89 1.21 Allowed 'General case' 0 C--O 1.226 -0.18 0 O-C-N 119.735 -1.853 . . . . 4.8600000000000003 109.078 -171.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 16.0 t -103.95 -26.81 3.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 C-N-CA 124.17 0.988 . . . . 1.6699999999999999 108.859 176.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -151.28 86.93 1.36 Allowed 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 107.415 -1.328 . . . . 3.0099999999999998 107.415 -176.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 28.2 mm -114.71 134.59 57.25 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.488 0 N-CA-C 105.423 -2.065 . . . . 1.3899999999999999 105.423 176.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 23.5 p80 -123.27 80.16 52.71 Favored Pre-proline 0 N--CA 1.444 -0.762 0 N-CA-C 107.564 -1.273 . . . . 0.55000000000000004 107.564 176.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -80.84 65.87 8.88 Favored 'Trans proline' 0 N--CA 1.452 -0.954 0 C-N-CA 121.944 1.762 . . . . 0.57999999999999996 108.98 -179.566 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.022 0 C-N-CA 126.066 1.746 . . . . 6.4000000000000004 108.22 -178.291 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.478 0.936 0 CA-C-O 120.708 0.29 . . . . 1.8300000000000001 111.337 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 41.8 ttp180 -94.61 45.57 1.12 Allowed 'General case' 0 C--N 1.341 0.198 0 O-C-N 119.727 -1.858 . . . . 4.8799999999999999 109.476 -170.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 22.6 t -103.05 -27.4 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 C-N-CA 124.106 0.963 . . . . 1.5 109.104 177.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 16.5 t80 -150.64 85.98 1.38 Allowed 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 107.356 -1.35 . . . . 3.8900000000000001 107.356 -176.208 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 27.7 mm -114.26 133.71 59.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 N-CA-C 105.62 -1.993 . . . . 1.6299999999999999 105.62 176.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 22.1 p80 -122.12 79.88 43.41 Favored Pre-proline 0 N--CA 1.444 -0.743 0 N-CA-C 107.765 -1.198 . . . . 0.5 107.765 176.126 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -79.4 69.73 7.8 Favored 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 121.861 1.707 . . . . 0.51000000000000001 108.571 178.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.011 0 CA-C-O 116.821 -1.562 . . . . 6.25 108.75 179.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 . . . . . 0 N--CA 1.479 1.016 0 N-CA-C 111.873 0.323 . . . . 1.6200000000000001 111.873 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 25.2 ttm180 -92.71 49.9 1.52 Allowed 'General case' 0 C--O 1.224 -0.259 0 O-C-N 119.842 -1.786 . . . . 5.9199999999999999 108.83 -173.243 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 42.9 t -103.89 -27.27 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 C-N-CA 123.876 0.87 . . . . 1.5700000000000001 109.112 172.302 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 15.7 t80 -150.07 87.06 1.45 Allowed 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 108.316 -0.994 . . . . 2.9100000000000001 108.316 -175.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 39.8 mm -117.38 130.7 71.87 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 N-CA-C 106.012 -1.847 . . . . 1.72 106.012 179.008 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 22.0 p80 -122.29 81.79 45.42 Favored Pre-proline 0 N--CA 1.446 -0.664 0 N-CA-C 107.249 -1.389 . . . . 0.48999999999999999 107.249 178.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -82.25 63.97 8.26 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 122.307 2.004 . . . . 0.58999999999999997 108.352 -179.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.254 1.302 0 C-N-CA 125.902 1.681 . . . . 6.29 108.208 -178.7 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 . . . . . 0 N--CA 1.481 1.092 0 N-CA-C 113.127 0.788 . . . . 0.0 113.127 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 20.6 ttp180 -92.33 42.5 1.1 Allowed 'General case' 0 C--N 1.34 0.193 0 O-C-N 119.618 -1.926 . . . . 0.0 110.463 -168.051 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 38.5 t -97.43 -28.01 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 C-N-CA 125.49 1.516 . . . . 0.0 108.64 175.234 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 31.2 t80 -148.98 86.03 1.49 Allowed 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 -177.371 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 27.7 mm -114.04 136.05 51.78 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.484 0 N-CA-C 105.45 -2.056 . . . . 0.0 105.45 174.611 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 18.0 p80 -124.77 77.1 65.14 Favored Pre-proline 0 N--CA 1.443 -0.776 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 176.606 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -74.77 86.39 1.39 Allowed 'Trans proline' 0 N--CA 1.45 -1.064 0 C-N-CA 121.612 1.541 . . . . 0.0 108.555 -175.634 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 2.7 t80 . . . . . 0 C--O 1.249 1.054 0 CA-C-O 117.405 -1.283 . . . . 0.0 107.751 177.433 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 . . . . . 0 N--CA 1.481 1.095 0 N-CA-C 113.109 0.781 . . . . 1.9399999999999999 113.109 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 15.2 ttp180 -97.12 46.12 1.04 Allowed 'General case' 0 C--N 1.341 0.224 0 O-C-N 119.475 -2.015 . . . . 4.0700000000000003 109.748 -170.471 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 24.7 t -98.77 -27.8 3.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 123.983 0.913 . . . . 0.33000000000000002 108.787 176.332 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 60.0 t80 -152.86 84.17 1.22 Allowed 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 108.781 -0.822 . . . . 1.8 108.781 -175.173 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.472 HG22 ' HD3' ' A' ' 7' ' ' PRO . 35.8 mm -114.99 128.47 72.13 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 N-CA-C 106.215 -1.772 . . . . 0.28000000000000003 106.215 179.198 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 21.5 p80 -121.91 80.99 42.15 Favored Pre-proline 0 N--CA 1.445 -0.68 0 N-CA-C 107.302 -1.37 . . . . 0.40999999999999998 107.302 178.113 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.472 ' HD3' HG22 ' A' ' 5' ' ' ILE . 89.8 Cg_endo -81.73 64.65 8.58 Favored 'Trans proline' 0 N--CA 1.451 -0.974 0 C-N-CA 122.211 1.941 . . . . 0.68000000000000005 108.244 179.379 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.023 0 C-N-CA 125.706 1.602 . . . . 5.2699999999999996 108.518 -178.871 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 . . . . . 0 N--CA 1.482 1.126 0 N-CA-C 112.945 0.72 . . . . 1.6100000000000001 112.945 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 2.2 ttt85 -98.17 47.78 1.0 Allowed 'General case' 0 C--O 1.225 -0.219 0 O-C-N 119.563 -1.961 . . . . 4.4400000000000004 108.978 -170.865 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 24.1 t -100.34 -26.89 3.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 108.945 -0.761 . . . . 0.23999999999999999 108.945 175.799 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 24.7 t80 -153.38 83.48 1.19 Allowed 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 108.644 -0.873 . . . . 1.8600000000000001 108.644 -175.781 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.626 HG22 ' HD3' ' A' ' 7' ' ' PRO . 31.7 mm -113.04 132.36 62.08 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 N-CA-C 105.977 -1.86 . . . . 0.20999999999999999 105.977 178.037 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 16.3 p80 -124.65 72.66 61.11 Favored Pre-proline 0 N--CA 1.447 -0.6 0 N-CA-C 108.626 -0.879 . . . . 0.67000000000000004 108.626 179.478 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.626 ' HD3' HG22 ' A' ' 5' ' ' ILE . 47.4 Cg_endo -72.48 90.58 0.79 Allowed 'Trans proline' 0 N--CA 1.45 -1.085 0 C-N-CA 121.762 1.641 . . . . 0.65000000000000002 108.709 -178.574 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 51.0 t80 . . . . . 0 C--O 1.252 1.206 0 CA-C-O 116.474 -1.726 . . . . 5.71 107.65 170.829 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 . . . . . 0 N--CA 1.483 1.194 0 N-CA-C 112.838 0.681 . . . . 2.0099999999999998 112.838 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 34.3 ttm180 -97.43 47.18 1.03 Allowed 'General case' 0 C--O 1.225 -0.228 0 O-C-N 119.708 -1.87 . . . . 5.0499999999999998 109.216 -170.79 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 20.3 t -100.07 -27.11 3.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 108.614 -0.884 . . . . 0.28999999999999998 108.614 175.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 43.7 t80 -153.25 84.17 1.2 Allowed 'General case' 0 N--CA 1.441 -0.911 0 N-CA-C 108.713 -0.847 . . . . 1.8200000000000001 108.713 -176.256 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.515 HG22 ' HD3' ' A' ' 7' ' ' PRO . 29.0 mm -112.87 132.24 62.21 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 N-CA-C 105.59 -2.004 . . . . 0.19 105.59 176.895 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 20.1 p80 -122.87 81.39 49.77 Favored Pre-proline 0 N--CA 1.444 -0.744 0 N-CA-C 107.215 -1.402 . . . . 0.40999999999999998 107.215 175.726 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.515 ' HD3' HG22 ' A' ' 5' ' ' ILE . 97.7 Cg_endo -80.91 66.13 8.86 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 121.878 1.719 . . . . 0.64000000000000001 108.42 178.831 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.023 0 CA-C-O 116.742 -1.599 . . . . 5.2699999999999996 108.513 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 . . . . . 0 N--CA 1.482 1.14 0 N-CA-C 112.754 0.65 . . . . 1.8400000000000001 112.754 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 7.5 ttp85 -97.51 45.69 1.03 Allowed 'General case' 0 C--N 1.34 0.163 0 O-C-N 119.686 -1.884 . . . . 4.5099999999999998 109.364 -170.77 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 21.1 t -98.94 -27.72 3.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 108.896 -0.779 . . . . 0.29999999999999999 108.896 176.726 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 38.4 t80 -152.98 83.35 1.21 Allowed 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 108.355 -0.979 . . . . 1.8100000000000001 108.355 -175.744 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.546 HG22 ' HD3' ' A' ' 7' ' ' PRO . 29.0 mm -112.14 131.42 63.62 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 N-CA-C 105.871 -1.9 . . . . 0.20000000000000001 105.871 177.238 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 21.0 p80 -122.38 78.96 45.37 Favored Pre-proline 0 N--CA 1.444 -0.737 0 N-CA-C 107.551 -1.278 . . . . 0.42999999999999999 107.551 176.484 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.546 ' HD3' HG22 ' A' ' 5' ' ' ILE . 73.4 Cg_endo -79.69 70.11 7.65 Favored 'Trans proline' 0 N--CA 1.45 -1.029 0 C-N-CA 121.832 1.688 . . . . 0.58999999999999997 108.537 179.498 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.252 1.212 0 CA-C-O 116.93 -1.51 . . . . 5.1399999999999997 108.635 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 . . . . . 0 N--CA 1.483 1.177 0 N-CA-C 114.165 1.172 . . . . 1.9099999999999999 114.165 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 53.1 ttp180 -96.15 51.44 1.22 Allowed 'General case' 0 C--O 1.227 -0.117 0 O-C-N 119.724 -1.86 . . . . 4.04 109.253 -171.73 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 38.8 t -102.81 -27.53 3.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 124.391 1.077 . . . . 0.25 108.777 173.172 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 85.6 t80 -152.78 86.26 1.26 Allowed 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 108.893 -0.78 . . . . 2.6400000000000001 108.893 -174.604 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.479 HG22 ' HD3' ' A' ' 7' ' ' PRO . 40.6 mm -118.75 131.88 70.25 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 N-CA-C 106.031 -1.84 . . . . 0.22 106.031 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 13.5 p80 -125.71 73.15 69.26 Favored Pre-proline 0 N--CA 1.448 -0.527 0 N-CA-C 108.527 -0.916 . . . . 0.65000000000000002 108.527 -178.576 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.479 ' HD3' HG22 ' A' ' 5' ' ' ILE . 71.4 Cg_endo -74.72 90.23 1.07 Allowed 'Trans proline' 0 N--CA 1.446 -1.296 0 C-N-CA 122.492 2.128 . . . . 0.67000000000000004 107.963 -177.723 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 37.7 t80 . . . . . 0 C--O 1.25 1.112 0 C-N-CA 125.661 1.584 . . . . 5.7599999999999998 108.361 172.766 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 . . . . . 0 N--CA 1.481 1.104 0 N-CA-C 113.08 0.77 . . . . 2.0699999999999998 113.08 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 22.2 ttm180 -99.21 48.54 0.95 Allowed 'General case' 0 C--N 1.341 0.203 0 O-C-N 119.602 -1.937 . . . . 5.0499999999999998 108.978 -170.701 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.1 t -100.01 -26.87 3.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 108.962 -0.755 . . . . 0.23000000000000001 108.962 175.283 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 57.2 t80 -153.5 84.42 1.18 Allowed 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 108.717 -0.846 . . . . 2.6299999999999999 108.717 -174.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.499 HG22 ' HD3' ' A' ' 7' ' ' PRO . 36.1 mm -115.91 130.61 70.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 N-CA-C 106.2 -1.778 . . . . 0.26000000000000001 106.2 179.6 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 14.8 p80 -124.69 73.44 62.61 Favored Pre-proline 0 N--CA 1.449 -0.499 0 N-CA-C 108.469 -0.937 . . . . 0.73999999999999999 108.469 -178.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.499 ' HD3' HG22 ' A' ' 5' ' ' ILE . 57.9 Cg_endo -74.7 88.49 1.19 Allowed 'Trans proline' 0 N--CA 1.447 -1.214 0 C-N-CA 122.171 1.914 . . . . 0.62 108.118 -178.501 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 23.4 t80 . . . . . 0 C--O 1.25 1.087 0 C-N-CA 125.688 1.595 . . . . 6.04 108.002 171.717 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 . . . . . 0 N--CA 1.482 1.129 0 N-CA-C 112.85 0.685 . . . . 1.9099999999999999 112.85 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 24.9 ttp-105 -96.76 47.97 1.06 Allowed 'General case' 0 CA--C 1.521 -0.146 0 O-C-N 119.636 -1.915 . . . . 4.5300000000000002 109.178 -169.839 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 43.7 t -99.57 -26.82 3.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 108.709 -0.849 . . . . 0.31 108.709 173.677 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 33.0 t80 -152.8 85.07 1.23 Allowed 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 108.99 -0.745 . . . . 2.6899999999999999 108.99 -175.843 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.494 HG22 ' HD3' ' A' ' 7' ' ' PRO . 30.6 mm -113.77 135.55 53.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 N-CA-C 105.517 -2.031 . . . . 0.20999999999999999 105.517 177.131 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 12.5 p80 -126.58 73.4 74.29 Favored Pre-proline 0 N--CA 1.447 -0.612 0 N-CA-C 108.3 -1.0 . . . . 0.66000000000000003 108.3 179.077 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.494 ' HD3' HG22 ' A' ' 5' ' ' ILE . 61.1 Cg_endo -73.67 91.08 0.9 Allowed 'Trans proline' 0 N--CA 1.448 -1.167 0 C-N-CA 122.292 1.995 . . . . 0.69999999999999996 108.16 -178.655 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 25.5 t80 . . . . . 0 C--O 1.249 1.066 0 C-N-CA 125.8 1.64 . . . . 6.3600000000000003 108.332 172.307 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 . . . . . 0 N--CA 1.48 1.062 0 N-CA-C 112.265 0.469 . . . . 1.8200000000000001 112.265 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 5.0 ttm180 -95.74 46.2 1.09 Allowed 'General case' 0 C--O 1.225 -0.207 0 O-C-N 119.68 -1.887 . . . . 4.7199999999999998 109.37 -171.036 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 22.3 t -99.98 -26.72 3.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 123.654 0.781 . . . . 0.29999999999999999 108.927 176.206 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 48.0 t80 -152.64 85.86 1.26 Allowed 'General case' 0 N--CA 1.441 -0.911 0 N-CA-C 107.763 -1.199 . . . . 2.1000000000000001 107.763 -175.5 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.546 HG22 ' HD3' ' A' ' 7' ' ' PRO . 28.8 mm -114.73 130.74 68.62 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.502 0 N-CA-C 105.532 -2.025 . . . . 0.20000000000000001 105.532 177.128 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 21.9 p80 -122.35 81.33 45.74 Favored Pre-proline 0 N--CA 1.443 -0.807 0 N-CA-C 107.382 -1.34 . . . . 0.40000000000000002 107.382 175.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.546 ' HD3' HG22 ' A' ' 5' ' ' ILE . 72.0 Cg_endo -80.94 65.0 8.96 Favored 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 121.796 1.664 . . . . 0.64000000000000001 108.518 178.258 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.254 1.306 0 C-N-CA 125.78 1.632 . . . . 5.0700000000000003 108.222 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 31.9 m-20 . . . . . 0 N--CA 1.479 0.998 0 N-CA-C 112.299 0.481 . . . . 1.8 112.299 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 41.1 ttp85 -93.76 44.01 1.12 Allowed 'General case' 0 C--N 1.341 0.215 0 O-C-N 119.788 -1.82 . . . . 4.1399999999999997 109.859 -171.152 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 22.2 t -101.29 -27.3 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 C-N-CA 124.153 0.981 . . . . 0.28000000000000003 108.882 177.597 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 15.3 t80 -150.97 87.84 1.43 Allowed 'General case' 0 N--CA 1.443 -0.821 0 N-CA-C 107.915 -1.142 . . . . 1.78 107.915 -176.024 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.457 HG22 ' HD3' ' A' ' 7' ' ' PRO . 37.6 mm -117.76 134.03 62.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 106.079 -1.822 . . . . 0.22 106.079 178.914 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 17.6 p80 -125.0 72.86 64.8 Favored Pre-proline 0 N--CA 1.45 -0.457 0 N-CA-C 108.667 -0.864 . . . . 0.46999999999999997 108.667 -178.591 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.457 ' HD3' HG22 ' A' ' 5' ' ' ILE . 60.0 Cg_endo -74.09 90.82 0.96 Allowed 'Trans proline' 0 N--CA 1.447 -1.214 0 C-N-CA 122.426 2.084 . . . . 0.80000000000000004 108.11 -179.104 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 14.7 t80 . . . . . 0 C--O 1.249 1.049 0 C-N-CA 125.728 1.611 . . . . 6.5199999999999996 108.34 171.502 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 . . . . . 0 N--CA 1.48 1.025 0 CA-C-O 120.592 0.234 . . . . 1.6799999999999999 111.437 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 23.5 ttm180 -95.23 48.48 1.17 Allowed 'General case' 0 C--O 1.226 -0.162 0 O-C-N 119.715 -1.866 . . . . 4.9800000000000004 108.874 -171.154 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 20.2 t -104.41 -26.12 3.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 C-N-CA 123.82 0.848 . . . . 0.23000000000000001 109.015 175.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 18.4 t80 -151.67 86.87 1.34 Allowed 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 107.853 -1.166 . . . . 1.78 107.853 -176.244 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.423 HG22 ' HD3' ' A' ' 7' ' ' PRO . 35.8 mm -116.67 130.71 71.07 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 N-CA-C 106.026 -1.842 . . . . 0.17999999999999999 106.026 178.735 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 21.5 p80 -121.15 81.65 36.81 Favored Pre-proline 0 N--CA 1.446 -0.67 0 N-CA-C 107.389 -1.337 . . . . 0.46000000000000002 107.389 178.035 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.423 ' HD3' HG22 ' A' ' 5' ' ' ILE . 84.1 Cg_endo -81.56 64.4 8.63 Favored 'Trans proline' 0 N--CA 1.451 -0.992 0 C-N-CA 122.191 1.927 . . . . 0.57999999999999996 108.45 178.96 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.084 0 CA-C-O 116.681 -1.628 . . . . 5.0999999999999996 108.207 -179.457 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 . . . . . 0 N--CA 1.48 1.053 0 N-CA-C 111.728 0.27 . . . . 1.72 111.728 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 20.8 ttm180 -93.37 49.1 1.36 Allowed 'General case' 0 C--O 1.226 -0.183 0 O-C-N 119.776 -1.827 . . . . 4.7699999999999996 108.786 -173.302 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 23.9 t -104.93 -26.49 3.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 C-N-CA 123.911 0.884 . . . . 0.22 109.124 174.748 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 20.4 t80 -151.03 87.55 1.41 Allowed 'General case' 0 N--CA 1.442 -0.861 0 N-CA-C 107.683 -1.229 . . . . 1.8500000000000001 107.683 -176.352 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.448 HG22 ' HD3' ' A' ' 7' ' ' PRO . 36.7 mm -117.15 131.07 70.94 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 N-CA-C 105.922 -1.881 . . . . 0.17999999999999999 105.922 178.615 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 22.8 p80 -121.49 82.55 40.09 Favored Pre-proline 0 N--CA 1.444 -0.735 0 N-CA-C 107.285 -1.376 . . . . 0.54000000000000004 107.285 177.828 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.448 ' HD3' HG22 ' A' ' 5' ' ' ILE . 97.0 Cg_endo -81.92 62.33 8.12 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 122.297 1.998 . . . . 0.58999999999999997 108.433 178.523 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.253 1.269 0 C-N-CA 126.01 1.724 . . . . 5.1399999999999997 108.042 -179.266 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 . . . . . 0 N--CA 1.479 1.005 0 N-CA-C 112.153 0.427 . . . . 1.6299999999999999 112.153 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 33.3 ttp180 -90.85 42.21 1.09 Allowed 'General case' 0 C--N 1.34 0.175 0 O-C-N 119.841 -1.787 . . . . 3.8599999999999999 110.44 -170.612 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 54.5 t -97.68 -28.88 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 C-N-CA 124.631 1.173 . . . . 0.42999999999999999 108.978 174.279 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 22.1 t80 -148.48 88.75 1.65 Allowed 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 108.883 -0.784 . . . . 1.78 108.883 -175.217 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 45.0 mm -120.44 135.69 59.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 N-CA-C 105.963 -1.866 . . . . 0.26000000000000001 105.963 179.447 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 15.2 p80 -127.72 74.41 78.34 Favored Pre-proline 0 N--CA 1.449 -0.517 0 N-CA-C 108.364 -0.976 . . . . 0.47999999999999998 108.364 -177.027 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -75.08 88.17 1.27 Allowed 'Trans proline' 0 N--CA 1.447 -1.214 0 C-N-CA 122.828 2.352 . . . . 0.76000000000000001 108.397 -176.342 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 45.9 t80 . . . . . 0 C--O 1.249 1.045 0 C-N-CA 125.473 1.509 . . . . 5.9400000000000004 108.246 171.462 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 . . . . . 0 N--CA 1.48 1.044 0 N-CA-C 113.17 0.804 . . . . 1.5800000000000001 113.17 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 24.8 ttp180 -90.14 43.04 1.12 Allowed 'General case' 0 C--N 1.342 0.252 0 O-C-N 119.701 -1.875 . . . . 3.75 110.663 -171.519 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 32.6 t -99.25 -28.11 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 C-N-CA 125.568 1.547 . . . . 0.32000000000000001 108.626 175.503 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 40.9 t80 -150.2 89.75 1.61 Allowed 'General case' 0 N--CA 1.442 -0.869 0 N-CA-C 107.983 -1.118 . . . . 1.8 107.983 -175.703 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.419 HG22 ' HD3' ' A' ' 7' ' ' PRO . 31.7 mm -119.24 138.28 50.43 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.459 0 N-CA-C 105.308 -2.108 . . . . 0.34000000000000002 105.308 176.679 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 15.6 p80 -127.68 73.72 78.35 Favored Pre-proline 0 N--CA 1.446 -0.658 0 N-CA-C 108.309 -0.997 . . . . 0.54000000000000004 108.309 -179.17 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.419 ' HD3' HG22 ' A' ' 5' ' ' ILE . 61.5 Cg_endo -72.63 94.75 0.78 Allowed 'Trans proline' 0 N--CA 1.447 -1.209 0 C-N-CA 121.646 1.564 . . . . 0.90000000000000002 108.771 -175.707 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 60.5 t80 . . . . . 0 C--O 1.253 1.28 0 CA-C-O 116.006 -1.95 . . . . 6.2699999999999996 106.751 171.313 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 . . . . . 0 N--CA 1.479 0.999 0 N-CA-C 112.204 0.446 . . . . 1.53 112.204 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 15.9 ttt180 -92.76 47.48 1.29 Allowed 'General case' 0 C--O 1.226 -0.173 0 O-C-N 119.958 -1.714 . . . . 3.8700000000000001 109.361 -172.437 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 23.5 t -103.59 -25.75 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 C-N-CA 123.992 0.917 . . . . 0.31 109.031 174.953 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 31.6 t80 -151.49 88.43 1.43 Allowed 'General case' 0 N--CA 1.44 -0.929 0 N-CA-C 107.854 -1.165 . . . . 2.27 107.854 -175.849 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.424 HG22 ' HD3' ' A' ' 7' ' ' PRO . 39.2 mm -119.12 133.42 66.0 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 N-CA-C 105.982 -1.859 . . . . 0.20999999999999999 105.982 179.316 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 15.0 p80 -124.8 73.8 63.98 Favored Pre-proline 0 N--CA 1.45 -0.464 0 N-CA-C 108.513 -0.921 . . . . 0.45000000000000001 108.513 -178.479 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.424 ' HD3' HG22 ' A' ' 5' ' ' ILE . 59.9 Cg_endo -74.29 89.72 1.05 Allowed 'Trans proline' 0 N--CA 1.447 -1.224 0 C-N-CA 122.415 2.076 . . . . 0.79000000000000004 108.144 -178.608 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 32.7 t80 . . . . . 0 C--O 1.249 1.031 0 C-N-CA 125.577 1.551 . . . . 5.9400000000000004 108.188 171.397 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 . . . . . 0 N--CA 1.477 0.924 0 CA-C-O 120.658 0.266 . . . . 1.5900000000000001 111.598 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 28.5 ttp180 -94.13 46.86 1.18 Allowed 'General case' 0 C--N 1.34 0.189 0 O-C-N 119.883 -1.761 . . . . 4.0599999999999996 109.48 -171.063 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 24.9 t -104.2 -27.2 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 C-N-CA 124.133 0.973 . . . . 0.22 109.171 176.475 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 24.6 t80 -150.29 87.5 1.46 Allowed 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 107.592 -1.262 . . . . 2.3500000000000001 107.592 -176.508 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.55 HG22 ' HD3' ' A' ' 7' ' ' PRO . 33.2 mm -116.56 131.94 67.67 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 N-CA-C 105.886 -1.894 . . . . 0.17000000000000001 105.886 177.856 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 23.3 p80 -121.58 81.96 40.27 Favored Pre-proline 0 N--CA 1.445 -0.696 0 N-CA-C 107.481 -1.303 . . . . 0.55000000000000004 107.481 176.949 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.55 ' HD3' HG22 ' A' ' 5' ' ' ILE . 85.3 Cg_endo -81.53 60.64 7.75 Favored 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 122.121 1.88 . . . . 0.65000000000000002 108.995 179.256 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.248 0.986 0 C-N-CA 126.264 1.826 . . . . 4.9699999999999998 108.049 -177.227 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 . . . . . 0 N--CA 1.48 1.033 0 N-CA-C 111.608 0.225 . . . . 1.78 111.608 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 25.6 ttm180 -93.48 48.4 1.3 Allowed 'General case' 0 C--O 1.225 -0.19 0 O-C-N 119.835 -1.791 . . . . 4.8600000000000003 109.016 -172.552 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 25.6 t -104.56 -26.76 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 C-N-CA 123.841 0.856 . . . . 0.25 109.198 175.136 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 32.4 t80 -150.8 87.28 1.41 Allowed 'General case' 0 N--CA 1.441 -0.91 0 N-CA-C 107.101 -1.444 . . . . 1.9199999999999999 107.101 -176.106 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.477 HG22 ' HD3' ' A' ' 7' ' ' PRO . 26.9 mm -115.64 132.65 64.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 105.205 -2.146 . . . . 0.20000000000000001 105.205 176.663 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 23.0 p80 -121.36 85.36 42.4 Favored Pre-proline 0 N--CA 1.442 -0.851 0 N-CA-C 107.028 -1.471 . . . . 0.56000000000000005 107.028 174.583 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.477 ' HD3' HG22 ' A' ' 5' ' ' ILE . 75.5 Cg_endo -81.42 58.69 6.99 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 122.079 1.852 . . . . 0.64000000000000001 108.761 176.252 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.254 1.297 0 C-N-CA 126.202 1.801 . . . . 5.21 107.711 -179.455 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 31.0 m-20 . . . . . 0 N--CA 1.479 1.014 0 N-CA-C 112.078 0.399 . . . . 1.53 112.078 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 3.2 ttp85 -92.82 44.65 1.16 Allowed 'General case' 0 C--N 1.339 0.124 0 O-C-N 119.897 -1.752 . . . . 4.4000000000000004 109.84 -171.066 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 24.2 t -101.89 -26.54 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 C-N-CA 123.917 0.887 . . . . 0.23000000000000001 108.939 176.41 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 27.9 t80 -150.99 87.48 1.41 Allowed 'General case' 0 N--CA 1.441 -0.911 0 N-CA-C 107.599 -1.26 . . . . 1.8100000000000001 107.599 -176.272 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.465 HG22 ' HD3' ' A' ' 7' ' ' PRO . 27.9 mm -115.87 133.25 62.89 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.514 0 N-CA-C 105.422 -2.066 . . . . 0.17999999999999999 105.422 176.814 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 21.0 p80 -121.67 83.2 41.87 Favored Pre-proline 0 N--CA 1.444 -0.743 0 N-CA-C 107.288 -1.375 . . . . 0.51000000000000001 107.288 175.696 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.465 ' HD3' HG22 ' A' ' 5' ' ' ILE . 94.2 Cg_endo -81.47 61.92 8.19 Favored 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 122.015 1.81 . . . . 0.59999999999999998 108.748 178.044 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.065 0 C-N-CA 126.252 1.821 . . . . 5.1100000000000003 108.133 -178.615 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 . . . . . 0 N--CA 1.48 1.037 0 CA-C-O 120.597 0.237 . . . . 1.8200000000000001 111.53 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 57.2 ttt180 -93.46 46.89 1.21 Allowed 'General case' 0 C--O 1.226 -0.18 0 O-C-N 119.735 -1.853 . . . . 3.9199999999999999 109.078 -171.777 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 16.0 t -103.95 -26.81 3.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 C-N-CA 124.17 0.988 . . . . 0.22 108.859 176.765 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -151.28 86.93 1.36 Allowed 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 107.415 -1.328 . . . . 1.8500000000000001 107.415 -176.841 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.51 HG22 ' HD3' ' A' ' 7' ' ' PRO . 28.2 mm -114.71 134.59 57.25 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.488 0 N-CA-C 105.423 -2.065 . . . . 0.17000000000000001 105.423 176.61 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 23.5 p80 -123.27 80.16 52.71 Favored Pre-proline 0 N--CA 1.444 -0.762 0 N-CA-C 107.564 -1.273 . . . . 0.55000000000000004 107.564 176.749 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.51 ' HD3' HG22 ' A' ' 5' ' ' ILE . 97.6 Cg_endo -80.84 65.87 8.88 Favored 'Trans proline' 0 N--CA 1.452 -0.954 0 C-N-CA 121.944 1.762 . . . . 0.57999999999999996 108.98 -179.566 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.022 0 C-N-CA 126.066 1.746 . . . . 5.0800000000000001 108.22 -178.291 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.478 0.936 0 CA-C-O 120.708 0.29 . . . . 1.8300000000000001 111.337 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 41.8 ttp180 -94.61 45.57 1.12 Allowed 'General case' 0 C--N 1.341 0.198 0 O-C-N 119.727 -1.858 . . . . 4.1799999999999997 109.476 -170.814 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 22.6 t -103.05 -27.4 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 C-N-CA 124.106 0.963 . . . . 0.20999999999999999 109.104 177.554 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 16.5 t80 -150.64 85.98 1.38 Allowed 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 107.356 -1.35 . . . . 2.3199999999999998 107.356 -176.208 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.535 HG22 ' HD3' ' A' ' 7' ' ' PRO . 27.7 mm -114.26 133.71 59.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 N-CA-C 105.62 -1.993 . . . . 0.16 105.62 176.772 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 22.1 p80 -122.12 79.88 43.41 Favored Pre-proline 0 N--CA 1.444 -0.743 0 N-CA-C 107.765 -1.198 . . . . 0.47999999999999998 107.765 176.126 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.535 ' HD3' HG22 ' A' ' 5' ' ' ILE . 73.4 Cg_endo -79.4 69.73 7.8 Favored 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 121.861 1.707 . . . . 0.51000000000000001 108.571 178.828 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.011 0 CA-C-O 116.821 -1.562 . . . . 5.0300000000000002 108.75 179.742 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 . . . . . 0 N--CA 1.479 1.016 0 N-CA-C 111.873 0.323 . . . . 1.6200000000000001 111.873 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 25.2 ttm180 -92.71 49.9 1.52 Allowed 'General case' 0 C--O 1.224 -0.259 0 O-C-N 119.842 -1.786 . . . . 4.8799999999999999 108.83 -173.243 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 42.9 t -103.89 -27.27 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 C-N-CA 123.876 0.87 . . . . 0.23999999999999999 109.112 172.302 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 15.7 t80 -150.07 87.06 1.45 Allowed 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 108.316 -0.994 . . . . 1.76 108.316 -175.773 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 39.8 mm -117.38 130.7 71.87 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 N-CA-C 106.012 -1.847 . . . . 0.17999999999999999 106.012 179.008 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 22.0 p80 -122.29 81.79 45.42 Favored Pre-proline 0 N--CA 1.446 -0.664 0 N-CA-C 107.249 -1.389 . . . . 0.47999999999999998 107.249 178.761 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -82.25 63.97 8.26 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 122.307 2.004 . . . . 0.58999999999999997 108.352 -179.774 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.254 1.302 0 C-N-CA 125.902 1.681 . . . . 5.0800000000000001 108.208 -178.7 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 . . . . . 0 N--CA 1.481 1.092 0 N-CA-C 113.127 0.788 . . . . 0.0 113.127 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 20.6 ttp180 -92.33 42.5 1.1 Allowed 'General case' 0 C--N 1.34 0.193 0 O-C-N 119.618 -1.926 . . . . 0.0 110.463 -168.051 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 38.5 t -97.43 -28.01 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 C-N-CA 125.49 1.516 . . . . 0.0 108.64 175.234 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 31.2 t80 -148.98 86.03 1.49 Allowed 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 -177.371 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.553 HG22 ' HD3' ' A' ' 7' ' ' PRO . 27.7 mm -114.04 136.05 51.78 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.484 0 N-CA-C 105.45 -2.056 . . . . 0.0 105.45 174.611 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 18.0 p80 -124.77 77.1 65.14 Favored Pre-proline 0 N--CA 1.443 -0.776 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 176.606 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.553 ' HD3' HG22 ' A' ' 5' ' ' ILE . 83.3 Cg_endo -74.77 86.39 1.39 Allowed 'Trans proline' 0 N--CA 1.45 -1.064 0 C-N-CA 121.612 1.541 . . . . 0.0 108.555 -175.634 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 2.7 t80 . . . . . 0 C--O 1.249 1.054 0 CA-C-O 117.405 -1.283 . . . . 0.0 107.751 177.433 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 . . . . . 0 N--CA 1.481 1.095 0 N-CA-C 113.109 0.781 . . . . 1.9399999999999999 113.109 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 15.2 ttp180 -97.12 46.12 1.04 Allowed 'General case' 0 C--N 1.341 0.224 0 O-C-N 119.475 -2.015 . . . . 4.0700000000000003 109.748 -170.471 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 24.7 t -98.77 -27.8 3.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 123.983 0.913 . . . . 0.33000000000000002 108.787 176.332 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 60.0 t80 -152.86 84.17 1.22 Allowed 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 108.781 -0.822 . . . . 1.8 108.781 -175.173 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.472 HG22 ' HD3' ' A' ' 7' ' ' PRO . 35.8 mm -114.99 128.47 72.13 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 N-CA-C 106.215 -1.772 . . . . 0.28000000000000003 106.215 179.198 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 21.5 p80 -121.91 80.99 42.15 Favored Pre-proline 0 N--CA 1.445 -0.68 0 N-CA-C 107.302 -1.37 . . . . 0.40999999999999998 107.302 178.113 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.472 ' HD3' HG22 ' A' ' 5' ' ' ILE . 89.8 Cg_endo -81.73 64.65 8.58 Favored 'Trans proline' 0 N--CA 1.451 -0.974 0 C-N-CA 122.211 1.941 . . . . 0.68000000000000005 108.244 179.379 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.023 0 C-N-CA 125.706 1.602 . . . . 5.2699999999999996 108.518 -178.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 . . . . . 0 N--CA 1.482 1.126 0 N-CA-C 112.945 0.72 . . . . 1.6100000000000001 112.945 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 2.2 ttt85 -98.17 47.78 1.0 Allowed 'General case' 0 C--O 1.225 -0.219 0 O-C-N 119.563 -1.961 . . . . 4.4400000000000004 108.978 -170.865 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 24.1 t -100.34 -26.89 3.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 108.945 -0.761 . . . . 0.23999999999999999 108.945 175.799 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 24.7 t80 -153.38 83.48 1.19 Allowed 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 108.644 -0.873 . . . . 1.8600000000000001 108.644 -175.781 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.626 HG22 ' HD3' ' A' ' 7' ' ' PRO . 31.7 mm -113.04 132.36 62.08 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 N-CA-C 105.977 -1.86 . . . . 0.20999999999999999 105.977 178.037 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 16.3 p80 -124.65 72.66 61.11 Favored Pre-proline 0 N--CA 1.447 -0.6 0 N-CA-C 108.626 -0.879 . . . . 0.67000000000000004 108.626 179.478 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.626 ' HD3' HG22 ' A' ' 5' ' ' ILE . 47.4 Cg_endo -72.48 90.58 0.79 Allowed 'Trans proline' 0 N--CA 1.45 -1.085 0 C-N-CA 121.762 1.641 . . . . 0.65000000000000002 108.709 -178.574 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 51.0 t80 . . . . . 0 C--O 1.252 1.206 0 CA-C-O 116.474 -1.726 . . . . 5.71 107.65 170.829 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 . . . . . 0 N--CA 1.483 1.194 0 N-CA-C 112.838 0.681 . . . . 2.0099999999999998 112.838 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 34.3 ttm180 -97.43 47.18 1.03 Allowed 'General case' 0 C--O 1.225 -0.228 0 O-C-N 119.708 -1.87 . . . . 5.0499999999999998 109.216 -170.79 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 20.3 t -100.07 -27.11 3.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 108.614 -0.884 . . . . 0.28999999999999998 108.614 175.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 43.7 t80 -153.25 84.17 1.2 Allowed 'General case' 0 N--CA 1.441 -0.911 0 N-CA-C 108.713 -0.847 . . . . 1.8200000000000001 108.713 -176.256 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.515 HG22 ' HD3' ' A' ' 7' ' ' PRO . 29.0 mm -112.87 132.24 62.21 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 N-CA-C 105.59 -2.004 . . . . 0.19 105.59 176.895 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 20.1 p80 -122.87 81.39 49.77 Favored Pre-proline 0 N--CA 1.444 -0.744 0 N-CA-C 107.215 -1.402 . . . . 0.40999999999999998 107.215 175.726 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.515 ' HD3' HG22 ' A' ' 5' ' ' ILE . 97.7 Cg_endo -80.91 66.13 8.86 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 121.878 1.719 . . . . 0.64000000000000001 108.42 178.831 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.023 0 CA-C-O 116.742 -1.599 . . . . 5.2699999999999996 108.513 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 . . . . . 0 N--CA 1.482 1.14 0 N-CA-C 112.754 0.65 . . . . 1.8400000000000001 112.754 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 7.5 ttp85 -97.51 45.69 1.03 Allowed 'General case' 0 C--N 1.34 0.163 0 O-C-N 119.686 -1.884 . . . . 4.5099999999999998 109.364 -170.77 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 21.1 t -98.94 -27.72 3.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 108.896 -0.779 . . . . 0.29999999999999999 108.896 176.726 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 38.4 t80 -152.98 83.35 1.21 Allowed 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 108.355 -0.979 . . . . 1.8100000000000001 108.355 -175.744 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.546 HG22 ' HD3' ' A' ' 7' ' ' PRO . 29.0 mm -112.14 131.42 63.62 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 N-CA-C 105.871 -1.9 . . . . 0.20000000000000001 105.871 177.238 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 21.0 p80 -122.38 78.96 45.37 Favored Pre-proline 0 N--CA 1.444 -0.737 0 N-CA-C 107.551 -1.278 . . . . 0.42999999999999999 107.551 176.484 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.546 ' HD3' HG22 ' A' ' 5' ' ' ILE . 73.4 Cg_endo -79.69 70.11 7.65 Favored 'Trans proline' 0 N--CA 1.45 -1.029 0 C-N-CA 121.832 1.688 . . . . 0.58999999999999997 108.537 179.498 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.252 1.212 0 CA-C-O 116.93 -1.51 . . . . 5.1399999999999997 108.635 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 . . . . . 0 N--CA 1.483 1.177 0 N-CA-C 114.165 1.172 . . . . 1.9099999999999999 114.165 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 53.1 ttp180 -96.15 51.44 1.22 Allowed 'General case' 0 C--O 1.227 -0.117 0 O-C-N 119.724 -1.86 . . . . 4.04 109.253 -171.73 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 38.8 t -102.81 -27.53 3.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 124.391 1.077 . . . . 0.25 108.777 173.172 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 85.6 t80 -152.78 86.26 1.26 Allowed 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 108.893 -0.78 . . . . 2.6400000000000001 108.893 -174.604 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.479 HG22 ' HD3' ' A' ' 7' ' ' PRO . 40.6 mm -118.75 131.88 70.25 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 N-CA-C 106.031 -1.84 . . . . 0.22 106.031 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 13.5 p80 -125.71 73.15 69.26 Favored Pre-proline 0 N--CA 1.448 -0.527 0 N-CA-C 108.527 -0.916 . . . . 0.65000000000000002 108.527 -178.576 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.479 ' HD3' HG22 ' A' ' 5' ' ' ILE . 71.4 Cg_endo -74.72 90.23 1.07 Allowed 'Trans proline' 0 N--CA 1.446 -1.296 0 C-N-CA 122.492 2.128 . . . . 0.67000000000000004 107.963 -177.723 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 37.7 t80 . . . . . 0 C--O 1.25 1.112 0 C-N-CA 125.661 1.584 . . . . 5.7599999999999998 108.361 172.766 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 . . . . . 0 N--CA 1.481 1.104 0 N-CA-C 113.08 0.77 . . . . 2.0699999999999998 113.08 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 22.2 ttm180 -99.21 48.54 0.95 Allowed 'General case' 0 C--N 1.341 0.203 0 O-C-N 119.602 -1.937 . . . . 5.0499999999999998 108.978 -170.701 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.1 t -100.01 -26.87 3.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 108.962 -0.755 . . . . 0.23000000000000001 108.962 175.283 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 57.2 t80 -153.5 84.42 1.18 Allowed 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 108.717 -0.846 . . . . 2.6299999999999999 108.717 -174.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.499 HG22 ' HD3' ' A' ' 7' ' ' PRO . 36.1 mm -115.91 130.61 70.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 N-CA-C 106.2 -1.778 . . . . 0.26000000000000001 106.2 179.6 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 14.8 p80 -124.69 73.44 62.61 Favored Pre-proline 0 N--CA 1.449 -0.499 0 N-CA-C 108.469 -0.937 . . . . 0.73999999999999999 108.469 -178.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.499 ' HD3' HG22 ' A' ' 5' ' ' ILE . 57.9 Cg_endo -74.7 88.49 1.19 Allowed 'Trans proline' 0 N--CA 1.447 -1.214 0 C-N-CA 122.171 1.914 . . . . 0.62 108.118 -178.501 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 23.4 t80 . . . . . 0 C--O 1.25 1.087 0 C-N-CA 125.688 1.595 . . . . 6.04 108.002 171.717 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 . . . . . 0 N--CA 1.482 1.129 0 N-CA-C 112.85 0.685 . . . . 1.9099999999999999 112.85 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 24.9 ttp-105 -96.76 47.97 1.06 Allowed 'General case' 0 CA--C 1.521 -0.146 0 O-C-N 119.636 -1.915 . . . . 4.5300000000000002 109.178 -169.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 43.7 t -99.57 -26.82 3.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 108.709 -0.849 . . . . 0.31 108.709 173.677 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 33.0 t80 -152.8 85.07 1.23 Allowed 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 108.99 -0.745 . . . . 2.6899999999999999 108.99 -175.843 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.494 HG22 ' HD3' ' A' ' 7' ' ' PRO . 30.6 mm -113.77 135.55 53.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 N-CA-C 105.517 -2.031 . . . . 0.20999999999999999 105.517 177.131 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 12.5 p80 -126.58 73.4 74.29 Favored Pre-proline 0 N--CA 1.447 -0.612 0 N-CA-C 108.3 -1.0 . . . . 0.66000000000000003 108.3 179.077 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.494 ' HD3' HG22 ' A' ' 5' ' ' ILE . 61.1 Cg_endo -73.67 91.08 0.9 Allowed 'Trans proline' 0 N--CA 1.448 -1.167 0 C-N-CA 122.292 1.995 . . . . 0.69999999999999996 108.16 -178.655 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 25.5 t80 . . . . . 0 C--O 1.249 1.066 0 C-N-CA 125.8 1.64 . . . . 6.3600000000000003 108.332 172.307 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 . . . . . 0 N--CA 1.48 1.062 0 N-CA-C 112.265 0.469 . . . . 1.8200000000000001 112.265 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 5.0 ttm180 -95.74 46.2 1.09 Allowed 'General case' 0 C--O 1.225 -0.207 0 O-C-N 119.68 -1.887 . . . . 4.7199999999999998 109.37 -171.036 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 22.3 t -99.98 -26.72 3.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 123.654 0.781 . . . . 0.29999999999999999 108.927 176.206 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 48.0 t80 -152.64 85.86 1.26 Allowed 'General case' 0 N--CA 1.441 -0.911 0 N-CA-C 107.763 -1.199 . . . . 2.1000000000000001 107.763 -175.5 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.546 HG22 ' HD3' ' A' ' 7' ' ' PRO . 28.8 mm -114.73 130.74 68.62 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.502 0 N-CA-C 105.532 -2.025 . . . . 0.20000000000000001 105.532 177.128 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 21.9 p80 -122.35 81.33 45.74 Favored Pre-proline 0 N--CA 1.443 -0.807 0 N-CA-C 107.382 -1.34 . . . . 0.40000000000000002 107.382 175.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.546 ' HD3' HG22 ' A' ' 5' ' ' ILE . 72.0 Cg_endo -80.94 65.0 8.96 Favored 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 121.796 1.664 . . . . 0.64000000000000001 108.518 178.258 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.254 1.306 0 C-N-CA 125.78 1.632 . . . . 5.0700000000000003 108.222 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 31.9 m-20 . . . . . 0 N--CA 1.479 0.998 0 N-CA-C 112.299 0.481 . . . . 1.8 112.299 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 41.1 ttp85 -93.76 44.01 1.12 Allowed 'General case' 0 C--N 1.341 0.215 0 O-C-N 119.788 -1.82 . . . . 4.1399999999999997 109.859 -171.152 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 22.2 t -101.29 -27.3 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 C-N-CA 124.153 0.981 . . . . 0.28000000000000003 108.882 177.597 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 15.3 t80 -150.97 87.84 1.43 Allowed 'General case' 0 N--CA 1.443 -0.821 0 N-CA-C 107.915 -1.142 . . . . 1.78 107.915 -176.024 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.457 HG22 ' HD3' ' A' ' 7' ' ' PRO . 37.6 mm -117.76 134.03 62.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 106.079 -1.822 . . . . 0.22 106.079 178.914 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 17.6 p80 -125.0 72.86 64.8 Favored Pre-proline 0 N--CA 1.45 -0.457 0 N-CA-C 108.667 -0.864 . . . . 0.46999999999999997 108.667 -178.591 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.457 ' HD3' HG22 ' A' ' 5' ' ' ILE . 60.0 Cg_endo -74.09 90.82 0.96 Allowed 'Trans proline' 0 N--CA 1.447 -1.214 0 C-N-CA 122.426 2.084 . . . . 0.80000000000000004 108.11 -179.104 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 14.7 t80 . . . . . 0 C--O 1.249 1.049 0 C-N-CA 125.728 1.611 . . . . 6.5199999999999996 108.34 171.502 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 . . . . . 0 N--CA 1.48 1.025 0 CA-C-O 120.592 0.234 . . . . 1.6799999999999999 111.437 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 23.5 ttm180 -95.23 48.48 1.17 Allowed 'General case' 0 C--O 1.226 -0.162 0 O-C-N 119.715 -1.866 . . . . 4.9800000000000004 108.874 -171.154 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 20.2 t -104.41 -26.12 3.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 C-N-CA 123.82 0.848 . . . . 0.23000000000000001 109.015 175.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 18.4 t80 -151.67 86.87 1.34 Allowed 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 107.853 -1.166 . . . . 1.78 107.853 -176.244 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.423 HG22 ' HD3' ' A' ' 7' ' ' PRO . 35.8 mm -116.67 130.71 71.07 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 N-CA-C 106.026 -1.842 . . . . 0.17999999999999999 106.026 178.735 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 21.5 p80 -121.15 81.65 36.81 Favored Pre-proline 0 N--CA 1.446 -0.67 0 N-CA-C 107.389 -1.337 . . . . 0.46000000000000002 107.389 178.035 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.423 ' HD3' HG22 ' A' ' 5' ' ' ILE . 84.1 Cg_endo -81.56 64.4 8.63 Favored 'Trans proline' 0 N--CA 1.451 -0.992 0 C-N-CA 122.191 1.927 . . . . 0.57999999999999996 108.45 178.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.084 0 CA-C-O 116.681 -1.628 . . . . 5.0999999999999996 108.207 -179.457 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 . . . . . 0 N--CA 1.48 1.053 0 N-CA-C 111.728 0.27 . . . . 1.72 111.728 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 20.8 ttm180 -93.37 49.1 1.36 Allowed 'General case' 0 C--O 1.226 -0.183 0 O-C-N 119.776 -1.827 . . . . 4.7699999999999996 108.786 -173.302 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 23.9 t -104.93 -26.49 3.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 C-N-CA 123.911 0.884 . . . . 0.22 109.124 174.748 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 20.4 t80 -151.03 87.55 1.41 Allowed 'General case' 0 N--CA 1.442 -0.861 0 N-CA-C 107.683 -1.229 . . . . 1.8500000000000001 107.683 -176.352 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.448 HG22 ' HD3' ' A' ' 7' ' ' PRO . 36.7 mm -117.15 131.07 70.94 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 N-CA-C 105.922 -1.881 . . . . 0.17999999999999999 105.922 178.615 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 22.8 p80 -121.49 82.55 40.09 Favored Pre-proline 0 N--CA 1.444 -0.735 0 N-CA-C 107.285 -1.376 . . . . 0.54000000000000004 107.285 177.828 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.448 ' HD3' HG22 ' A' ' 5' ' ' ILE . 97.0 Cg_endo -81.92 62.33 8.12 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 122.297 1.998 . . . . 0.58999999999999997 108.433 178.523 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.253 1.269 0 C-N-CA 126.01 1.724 . . . . 5.1399999999999997 108.042 -179.266 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 . . . . . 0 N--CA 1.479 1.005 0 N-CA-C 112.153 0.427 . . . . 1.6299999999999999 112.153 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 33.3 ttp180 -90.85 42.21 1.09 Allowed 'General case' 0 C--N 1.34 0.175 0 O-C-N 119.841 -1.787 . . . . 3.8599999999999999 110.44 -170.612 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 54.5 t -97.68 -28.88 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 C-N-CA 124.631 1.173 . . . . 0.42999999999999999 108.978 174.279 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 22.1 t80 -148.48 88.75 1.65 Allowed 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 108.883 -0.784 . . . . 1.78 108.883 -175.217 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 45.0 mm -120.44 135.69 59.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 N-CA-C 105.963 -1.866 . . . . 0.26000000000000001 105.963 179.447 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 15.2 p80 -127.72 74.41 78.34 Favored Pre-proline 0 N--CA 1.449 -0.517 0 N-CA-C 108.364 -0.976 . . . . 0.47999999999999998 108.364 -177.027 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -75.08 88.17 1.27 Allowed 'Trans proline' 0 N--CA 1.447 -1.214 0 C-N-CA 122.828 2.352 . . . . 0.76000000000000001 108.397 -176.342 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 45.9 t80 . . . . . 0 C--O 1.249 1.045 0 C-N-CA 125.473 1.509 . . . . 5.9400000000000004 108.246 171.462 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 . . . . . 0 N--CA 1.48 1.044 0 N-CA-C 113.17 0.804 . . . . 1.5800000000000001 113.17 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 24.8 ttp180 -90.14 43.04 1.12 Allowed 'General case' 0 C--N 1.342 0.252 0 O-C-N 119.701 -1.875 . . . . 3.75 110.663 -171.519 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 32.6 t -99.25 -28.11 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 C-N-CA 125.568 1.547 . . . . 0.32000000000000001 108.626 175.503 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 40.9 t80 -150.2 89.75 1.61 Allowed 'General case' 0 N--CA 1.442 -0.869 0 N-CA-C 107.983 -1.118 . . . . 1.8 107.983 -175.703 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.419 HG22 ' HD3' ' A' ' 7' ' ' PRO . 31.7 mm -119.24 138.28 50.43 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.459 0 N-CA-C 105.308 -2.108 . . . . 0.34000000000000002 105.308 176.679 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 15.6 p80 -127.68 73.72 78.35 Favored Pre-proline 0 N--CA 1.446 -0.658 0 N-CA-C 108.309 -0.997 . . . . 0.54000000000000004 108.309 -179.17 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.419 ' HD3' HG22 ' A' ' 5' ' ' ILE . 61.5 Cg_endo -72.63 94.75 0.78 Allowed 'Trans proline' 0 N--CA 1.447 -1.209 0 C-N-CA 121.646 1.564 . . . . 0.90000000000000002 108.771 -175.707 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 60.5 t80 . . . . . 0 C--O 1.253 1.28 0 CA-C-O 116.006 -1.95 . . . . 6.2699999999999996 106.751 171.313 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 . . . . . 0 N--CA 1.479 0.999 0 N-CA-C 112.204 0.446 . . . . 1.53 112.204 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 15.9 ttt180 -92.76 47.48 1.29 Allowed 'General case' 0 C--O 1.226 -0.173 0 O-C-N 119.958 -1.714 . . . . 3.8700000000000001 109.361 -172.437 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 23.5 t -103.59 -25.75 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 C-N-CA 123.992 0.917 . . . . 0.31 109.031 174.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 31.6 t80 -151.49 88.43 1.43 Allowed 'General case' 0 N--CA 1.44 -0.929 0 N-CA-C 107.854 -1.165 . . . . 2.27 107.854 -175.849 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.424 HG22 ' HD3' ' A' ' 7' ' ' PRO . 39.2 mm -119.12 133.42 66.0 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 N-CA-C 105.982 -1.859 . . . . 0.20999999999999999 105.982 179.316 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 15.0 p80 -124.8 73.8 63.98 Favored Pre-proline 0 N--CA 1.45 -0.464 0 N-CA-C 108.513 -0.921 . . . . 0.45000000000000001 108.513 -178.479 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.424 ' HD3' HG22 ' A' ' 5' ' ' ILE . 59.9 Cg_endo -74.29 89.72 1.05 Allowed 'Trans proline' 0 N--CA 1.447 -1.224 0 C-N-CA 122.415 2.076 . . . . 0.79000000000000004 108.144 -178.608 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 32.7 t80 . . . . . 0 C--O 1.249 1.031 0 C-N-CA 125.577 1.551 . . . . 5.9400000000000004 108.188 171.397 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 . . . . . 0 N--CA 1.477 0.924 0 CA-C-O 120.658 0.266 . . . . 1.5900000000000001 111.598 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 28.5 ttp180 -94.13 46.86 1.18 Allowed 'General case' 0 C--N 1.34 0.189 0 O-C-N 119.883 -1.761 . . . . 4.0599999999999996 109.48 -171.063 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 24.9 t -104.2 -27.2 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 C-N-CA 124.133 0.973 . . . . 0.22 109.171 176.475 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 24.6 t80 -150.29 87.5 1.46 Allowed 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 107.592 -1.262 . . . . 2.3500000000000001 107.592 -176.508 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.55 HG22 ' HD3' ' A' ' 7' ' ' PRO . 33.2 mm -116.56 131.94 67.67 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 N-CA-C 105.886 -1.894 . . . . 0.17000000000000001 105.886 177.856 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 23.3 p80 -121.58 81.96 40.27 Favored Pre-proline 0 N--CA 1.445 -0.696 0 N-CA-C 107.481 -1.303 . . . . 0.55000000000000004 107.481 176.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.55 ' HD3' HG22 ' A' ' 5' ' ' ILE . 85.3 Cg_endo -81.53 60.64 7.75 Favored 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 122.121 1.88 . . . . 0.65000000000000002 108.995 179.256 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.248 0.986 0 C-N-CA 126.264 1.826 . . . . 4.9699999999999998 108.049 -177.227 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 . . . . . 0 N--CA 1.48 1.033 0 N-CA-C 111.608 0.225 . . . . 1.78 111.608 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 25.6 ttm180 -93.48 48.4 1.3 Allowed 'General case' 0 C--O 1.225 -0.19 0 O-C-N 119.835 -1.791 . . . . 4.8600000000000003 109.016 -172.552 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 25.6 t -104.56 -26.76 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 C-N-CA 123.841 0.856 . . . . 0.25 109.198 175.136 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 32.4 t80 -150.8 87.28 1.41 Allowed 'General case' 0 N--CA 1.441 -0.91 0 N-CA-C 107.101 -1.444 . . . . 1.9199999999999999 107.101 -176.106 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.477 HG22 ' HD3' ' A' ' 7' ' ' PRO . 26.9 mm -115.64 132.65 64.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 105.205 -2.146 . . . . 0.20000000000000001 105.205 176.663 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 23.0 p80 -121.36 85.36 42.4 Favored Pre-proline 0 N--CA 1.442 -0.851 0 N-CA-C 107.028 -1.471 . . . . 0.56000000000000005 107.028 174.583 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.477 ' HD3' HG22 ' A' ' 5' ' ' ILE . 75.5 Cg_endo -81.42 58.69 6.99 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 122.079 1.852 . . . . 0.64000000000000001 108.761 176.252 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.254 1.297 0 C-N-CA 126.202 1.801 . . . . 5.21 107.711 -179.455 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 31.0 m-20 . . . . . 0 N--CA 1.479 1.014 0 N-CA-C 112.078 0.399 . . . . 1.53 112.078 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 3.2 ttp85 -92.82 44.65 1.16 Allowed 'General case' 0 C--N 1.339 0.124 0 O-C-N 119.897 -1.752 . . . . 4.4000000000000004 109.84 -171.066 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 24.2 t -101.89 -26.54 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 C-N-CA 123.917 0.887 . . . . 0.23000000000000001 108.939 176.41 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 27.9 t80 -150.99 87.48 1.41 Allowed 'General case' 0 N--CA 1.441 -0.911 0 N-CA-C 107.599 -1.26 . . . . 1.8100000000000001 107.599 -176.272 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.465 HG22 ' HD3' ' A' ' 7' ' ' PRO . 27.9 mm -115.87 133.25 62.89 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.514 0 N-CA-C 105.422 -2.066 . . . . 0.17999999999999999 105.422 176.814 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 21.0 p80 -121.67 83.2 41.87 Favored Pre-proline 0 N--CA 1.444 -0.743 0 N-CA-C 107.288 -1.375 . . . . 0.51000000000000001 107.288 175.696 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.465 ' HD3' HG22 ' A' ' 5' ' ' ILE . 94.2 Cg_endo -81.47 61.92 8.19 Favored 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 122.015 1.81 . . . . 0.59999999999999998 108.748 178.044 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.065 0 C-N-CA 126.252 1.821 . . . . 5.1100000000000003 108.133 -178.615 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 . . . . . 0 N--CA 1.48 1.037 0 CA-C-O 120.597 0.237 . . . . 1.8200000000000001 111.53 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 57.2 ttt180 -93.46 46.89 1.21 Allowed 'General case' 0 C--O 1.226 -0.18 0 O-C-N 119.735 -1.853 . . . . 3.9199999999999999 109.078 -171.777 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 16.0 t -103.95 -26.81 3.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 C-N-CA 124.17 0.988 . . . . 0.22 108.859 176.765 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -151.28 86.93 1.36 Allowed 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 107.415 -1.328 . . . . 1.8500000000000001 107.415 -176.841 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.51 HG22 ' HD3' ' A' ' 7' ' ' PRO . 28.2 mm -114.71 134.59 57.25 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.488 0 N-CA-C 105.423 -2.065 . . . . 0.17000000000000001 105.423 176.61 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 23.5 p80 -123.27 80.16 52.71 Favored Pre-proline 0 N--CA 1.444 -0.762 0 N-CA-C 107.564 -1.273 . . . . 0.55000000000000004 107.564 176.749 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.51 ' HD3' HG22 ' A' ' 5' ' ' ILE . 97.6 Cg_endo -80.84 65.87 8.88 Favored 'Trans proline' 0 N--CA 1.452 -0.954 0 C-N-CA 121.944 1.762 . . . . 0.57999999999999996 108.98 -179.566 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.022 0 C-N-CA 126.066 1.746 . . . . 5.0800000000000001 108.22 -178.291 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.478 0.936 0 CA-C-O 120.708 0.29 . . . . 1.8300000000000001 111.337 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 41.8 ttp180 -94.61 45.57 1.12 Allowed 'General case' 0 C--N 1.341 0.198 0 O-C-N 119.727 -1.858 . . . . 4.1799999999999997 109.476 -170.814 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 22.6 t -103.05 -27.4 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 C-N-CA 124.106 0.963 . . . . 0.20999999999999999 109.104 177.554 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 16.5 t80 -150.64 85.98 1.38 Allowed 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 107.356 -1.35 . . . . 2.3199999999999998 107.356 -176.208 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.535 HG22 ' HD3' ' A' ' 7' ' ' PRO . 27.7 mm -114.26 133.71 59.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 N-CA-C 105.62 -1.993 . . . . 0.16 105.62 176.772 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 22.1 p80 -122.12 79.88 43.41 Favored Pre-proline 0 N--CA 1.444 -0.743 0 N-CA-C 107.765 -1.198 . . . . 0.47999999999999998 107.765 176.126 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.535 ' HD3' HG22 ' A' ' 5' ' ' ILE . 73.4 Cg_endo -79.4 69.73 7.8 Favored 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 121.861 1.707 . . . . 0.51000000000000001 108.571 178.828 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.011 0 CA-C-O 116.821 -1.562 . . . . 5.0300000000000002 108.75 179.742 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 . . . . . 0 N--CA 1.479 1.016 0 N-CA-C 111.873 0.323 . . . . 1.6200000000000001 111.873 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 25.2 ttm180 -92.71 49.9 1.52 Allowed 'General case' 0 C--O 1.224 -0.259 0 O-C-N 119.842 -1.786 . . . . 4.8799999999999999 108.83 -173.243 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 42.9 t -103.89 -27.27 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 C-N-CA 123.876 0.87 . . . . 0.23999999999999999 109.112 172.302 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 15.7 t80 -150.07 87.06 1.45 Allowed 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 108.316 -0.994 . . . . 1.76 108.316 -175.773 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 39.8 mm -117.38 130.7 71.87 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 N-CA-C 106.012 -1.847 . . . . 0.17999999999999999 106.012 179.008 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 22.0 p80 -122.29 81.79 45.42 Favored Pre-proline 0 N--CA 1.446 -0.664 0 N-CA-C 107.249 -1.389 . . . . 0.47999999999999998 107.249 178.761 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -82.25 63.97 8.26 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 122.307 2.004 . . . . 0.58999999999999997 108.352 -179.774 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.254 1.302 0 C-N-CA 125.902 1.681 . . . . 5.0800000000000001 108.208 -178.7 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 . . . . . 0 N--CA 1.481 1.092 0 N-CA-C 113.127 0.788 . . . . 0.0 113.127 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 20.6 ttp180 -92.33 42.5 1.1 Allowed 'General case' 0 C--N 1.34 0.193 0 O-C-N 119.618 -1.926 . . . . 0.0 110.463 -168.051 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 38.5 t -97.43 -28.01 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 C-N-CA 125.49 1.516 . . . . 0.0 108.64 175.234 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 31.2 t80 -148.98 86.03 1.49 Allowed 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 -177.371 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.553 HG22 ' HD3' ' A' ' 7' ' ' PRO . 27.7 mm -114.04 136.05 51.78 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.484 0 N-CA-C 105.45 -2.056 . . . . 0.0 105.45 174.611 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 18.0 p80 -124.77 77.1 65.14 Favored Pre-proline 0 N--CA 1.443 -0.776 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 176.606 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.553 ' HD3' HG22 ' A' ' 5' ' ' ILE . 83.3 Cg_endo -74.77 86.39 1.39 Allowed 'Trans proline' 0 N--CA 1.45 -1.064 0 C-N-CA 121.612 1.541 . . . . 0.0 108.555 -175.634 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 2.7 t80 . . . . . 0 C--O 1.249 1.054 0 CA-C-O 117.405 -1.283 . . . . 0.0 107.751 177.433 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 . . . . . 0 N--CA 1.481 1.095 0 N-CA-C 113.109 0.781 . . . . 1.9399999999999999 113.109 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 15.2 ttp180 -97.12 46.12 1.04 Allowed 'General case' 0 C--N 1.341 0.224 0 O-C-N 119.475 -2.015 . . . . 4.0700000000000003 109.748 -170.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 24.7 t -98.77 -27.8 3.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 123.983 0.913 . . . . 0.33000000000000002 108.787 176.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 60.0 t80 -152.86 84.17 1.22 Allowed 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 108.781 -0.822 . . . . 1.8 108.781 -175.173 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.472 HG22 ' HD3' ' A' ' 7' ' ' PRO . 35.8 mm -114.99 128.47 72.13 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 N-CA-C 106.215 -1.772 . . . . 0.28000000000000003 106.215 179.198 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 21.5 p80 -121.91 80.99 42.15 Favored Pre-proline 0 N--CA 1.445 -0.68 0 N-CA-C 107.302 -1.37 . . . . 0.40999999999999998 107.302 178.113 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.472 ' HD3' HG22 ' A' ' 5' ' ' ILE . 89.8 Cg_endo -81.73 64.65 8.58 Favored 'Trans proline' 0 N--CA 1.451 -0.974 0 C-N-CA 122.211 1.941 . . . . 0.68000000000000005 108.244 179.379 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.023 0 C-N-CA 125.706 1.602 . . . . 5.2699999999999996 108.518 -178.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 . . . . . 0 N--CA 1.482 1.126 0 N-CA-C 112.945 0.72 . . . . 1.6100000000000001 112.945 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 2.2 ttt85 -98.17 47.78 1.0 Allowed 'General case' 0 C--O 1.225 -0.219 0 O-C-N 119.563 -1.961 . . . . 4.4400000000000004 108.978 -170.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 24.1 t -100.34 -26.89 3.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 108.945 -0.761 . . . . 0.23999999999999999 108.945 175.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 24.7 t80 -153.38 83.48 1.19 Allowed 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 108.644 -0.873 . . . . 1.8600000000000001 108.644 -175.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.626 HG22 ' HD3' ' A' ' 7' ' ' PRO . 31.7 mm -113.04 132.36 62.08 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 N-CA-C 105.977 -1.86 . . . . 0.20999999999999999 105.977 178.037 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 16.3 p80 -124.65 72.66 61.11 Favored Pre-proline 0 N--CA 1.447 -0.6 0 N-CA-C 108.626 -0.879 . . . . 0.67000000000000004 108.626 179.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.626 ' HD3' HG22 ' A' ' 5' ' ' ILE . 47.4 Cg_endo -72.48 90.58 0.79 Allowed 'Trans proline' 0 N--CA 1.45 -1.085 0 C-N-CA 121.762 1.641 . . . . 0.65000000000000002 108.709 -178.574 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 51.0 t80 . . . . . 0 C--O 1.252 1.206 0 CA-C-O 116.474 -1.726 . . . . 5.71 107.65 170.829 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 . . . . . 0 N--CA 1.483 1.194 0 N-CA-C 112.838 0.681 . . . . 2.0099999999999998 112.838 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 34.3 ttm180 -97.43 47.18 1.03 Allowed 'General case' 0 C--O 1.225 -0.228 0 O-C-N 119.708 -1.87 . . . . 5.0499999999999998 109.216 -170.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 20.3 t -100.07 -27.11 3.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 108.614 -0.884 . . . . 0.28999999999999998 108.614 175.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 43.7 t80 -153.25 84.17 1.2 Allowed 'General case' 0 N--CA 1.441 -0.911 0 N-CA-C 108.713 -0.847 . . . . 1.8200000000000001 108.713 -176.256 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.515 HG22 ' HD3' ' A' ' 7' ' ' PRO . 29.0 mm -112.87 132.24 62.21 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 N-CA-C 105.59 -2.004 . . . . 0.19 105.59 176.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 20.1 p80 -122.87 81.39 49.77 Favored Pre-proline 0 N--CA 1.444 -0.744 0 N-CA-C 107.215 -1.402 . . . . 0.40999999999999998 107.215 175.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.515 ' HD3' HG22 ' A' ' 5' ' ' ILE . 97.7 Cg_endo -80.91 66.13 8.86 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 121.878 1.719 . . . . 0.64000000000000001 108.42 178.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.023 0 CA-C-O 116.742 -1.599 . . . . 5.2699999999999996 108.513 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 . . . . . 0 N--CA 1.482 1.14 0 N-CA-C 112.754 0.65 . . . . 1.8400000000000001 112.754 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 7.5 ttp85 -97.51 45.69 1.03 Allowed 'General case' 0 C--N 1.34 0.163 0 O-C-N 119.686 -1.884 . . . . 4.5099999999999998 109.364 -170.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 21.1 t -98.94 -27.72 3.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 108.896 -0.779 . . . . 0.29999999999999999 108.896 176.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 38.4 t80 -152.98 83.35 1.21 Allowed 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 108.355 -0.979 . . . . 1.8100000000000001 108.355 -175.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.546 HG22 ' HD3' ' A' ' 7' ' ' PRO . 29.0 mm -112.14 131.42 63.62 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 N-CA-C 105.871 -1.9 . . . . 0.20000000000000001 105.871 177.238 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 21.0 p80 -122.38 78.96 45.37 Favored Pre-proline 0 N--CA 1.444 -0.737 0 N-CA-C 107.551 -1.278 . . . . 0.42999999999999999 107.551 176.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.546 ' HD3' HG22 ' A' ' 5' ' ' ILE . 73.4 Cg_endo -79.69 70.11 7.65 Favored 'Trans proline' 0 N--CA 1.45 -1.029 0 C-N-CA 121.832 1.688 . . . . 0.58999999999999997 108.537 179.498 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.252 1.212 0 CA-C-O 116.93 -1.51 . . . . 5.1399999999999997 108.635 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 . . . . . 0 N--CA 1.483 1.177 0 N-CA-C 114.165 1.172 . . . . 1.9099999999999999 114.165 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 53.1 ttp180 -96.15 51.44 1.22 Allowed 'General case' 0 C--O 1.227 -0.117 0 O-C-N 119.724 -1.86 . . . . 4.04 109.253 -171.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 38.8 t -102.81 -27.53 3.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 124.391 1.077 . . . . 0.25 108.777 173.172 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 85.6 t80 -152.78 86.26 1.26 Allowed 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 108.893 -0.78 . . . . 2.6400000000000001 108.893 -174.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.479 HG22 ' HD3' ' A' ' 7' ' ' PRO . 40.6 mm -118.75 131.88 70.25 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 N-CA-C 106.031 -1.84 . . . . 0.22 106.031 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 13.5 p80 -125.71 73.15 69.26 Favored Pre-proline 0 N--CA 1.448 -0.527 0 N-CA-C 108.527 -0.916 . . . . 0.65000000000000002 108.527 -178.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.479 ' HD3' HG22 ' A' ' 5' ' ' ILE . 71.4 Cg_endo -74.72 90.23 1.07 Allowed 'Trans proline' 0 N--CA 1.446 -1.296 0 C-N-CA 122.492 2.128 . . . . 0.67000000000000004 107.963 -177.723 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 37.7 t80 . . . . . 0 C--O 1.25 1.112 0 C-N-CA 125.661 1.584 . . . . 5.7599999999999998 108.361 172.766 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 . . . . . 0 N--CA 1.481 1.104 0 N-CA-C 113.08 0.77 . . . . 2.0699999999999998 113.08 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 22.2 ttm180 -99.21 48.54 0.95 Allowed 'General case' 0 C--N 1.341 0.203 0 O-C-N 119.602 -1.937 . . . . 5.0499999999999998 108.978 -170.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.1 t -100.01 -26.87 3.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 108.962 -0.755 . . . . 0.23000000000000001 108.962 175.283 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 57.2 t80 -153.5 84.42 1.18 Allowed 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 108.717 -0.846 . . . . 2.6299999999999999 108.717 -174.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.499 HG22 ' HD3' ' A' ' 7' ' ' PRO . 36.1 mm -115.91 130.61 70.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 N-CA-C 106.2 -1.778 . . . . 0.26000000000000001 106.2 179.6 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 14.8 p80 -124.69 73.44 62.61 Favored Pre-proline 0 N--CA 1.449 -0.499 0 N-CA-C 108.469 -0.937 . . . . 0.73999999999999999 108.469 -178.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.499 ' HD3' HG22 ' A' ' 5' ' ' ILE . 57.9 Cg_endo -74.7 88.49 1.19 Allowed 'Trans proline' 0 N--CA 1.447 -1.214 0 C-N-CA 122.171 1.914 . . . . 0.62 108.118 -178.501 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 23.4 t80 . . . . . 0 C--O 1.25 1.087 0 C-N-CA 125.688 1.595 . . . . 6.04 108.002 171.717 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 . . . . . 0 N--CA 1.482 1.129 0 N-CA-C 112.85 0.685 . . . . 1.9099999999999999 112.85 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 24.9 ttp-105 -96.76 47.97 1.06 Allowed 'General case' 0 CA--C 1.521 -0.146 0 O-C-N 119.636 -1.915 . . . . 4.5300000000000002 109.178 -169.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 43.7 t -99.57 -26.82 3.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 108.709 -0.849 . . . . 0.31 108.709 173.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 33.0 t80 -152.8 85.07 1.23 Allowed 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 108.99 -0.745 . . . . 2.6899999999999999 108.99 -175.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.494 HG22 ' HD3' ' A' ' 7' ' ' PRO . 30.6 mm -113.77 135.55 53.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 N-CA-C 105.517 -2.031 . . . . 0.20999999999999999 105.517 177.131 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 12.5 p80 -126.58 73.4 74.29 Favored Pre-proline 0 N--CA 1.447 -0.612 0 N-CA-C 108.3 -1.0 . . . . 0.66000000000000003 108.3 179.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.494 ' HD3' HG22 ' A' ' 5' ' ' ILE . 61.1 Cg_endo -73.67 91.08 0.9 Allowed 'Trans proline' 0 N--CA 1.448 -1.167 0 C-N-CA 122.292 1.995 . . . . 0.69999999999999996 108.16 -178.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 25.5 t80 . . . . . 0 C--O 1.249 1.066 0 C-N-CA 125.8 1.64 . . . . 6.3600000000000003 108.332 172.307 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 . . . . . 0 N--CA 1.48 1.062 0 N-CA-C 112.265 0.469 . . . . 1.8200000000000001 112.265 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 5.0 ttm180 -95.74 46.2 1.09 Allowed 'General case' 0 C--O 1.225 -0.207 0 O-C-N 119.68 -1.887 . . . . 4.7199999999999998 109.37 -171.036 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 22.3 t -99.98 -26.72 3.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 123.654 0.781 . . . . 0.29999999999999999 108.927 176.206 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 48.0 t80 -152.64 85.86 1.26 Allowed 'General case' 0 N--CA 1.441 -0.911 0 N-CA-C 107.763 -1.199 . . . . 2.1000000000000001 107.763 -175.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.546 HG22 ' HD3' ' A' ' 7' ' ' PRO . 28.8 mm -114.73 130.74 68.62 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.502 0 N-CA-C 105.532 -2.025 . . . . 0.20000000000000001 105.532 177.128 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 21.9 p80 -122.35 81.33 45.74 Favored Pre-proline 0 N--CA 1.443 -0.807 0 N-CA-C 107.382 -1.34 . . . . 0.40000000000000002 107.382 175.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.546 ' HD3' HG22 ' A' ' 5' ' ' ILE . 72.0 Cg_endo -80.94 65.0 8.96 Favored 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 121.796 1.664 . . . . 0.64000000000000001 108.518 178.258 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.254 1.306 0 C-N-CA 125.78 1.632 . . . . 5.0700000000000003 108.222 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 31.9 m-20 . . . . . 0 N--CA 1.479 0.998 0 N-CA-C 112.299 0.481 . . . . 1.8 112.299 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 41.1 ttp85 -93.76 44.01 1.12 Allowed 'General case' 0 C--N 1.341 0.215 0 O-C-N 119.788 -1.82 . . . . 4.1399999999999997 109.859 -171.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 22.2 t -101.29 -27.3 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 C-N-CA 124.153 0.981 . . . . 0.28000000000000003 108.882 177.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 15.3 t80 -150.97 87.84 1.43 Allowed 'General case' 0 N--CA 1.443 -0.821 0 N-CA-C 107.915 -1.142 . . . . 1.78 107.915 -176.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.457 HG22 ' HD3' ' A' ' 7' ' ' PRO . 37.6 mm -117.76 134.03 62.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 106.079 -1.822 . . . . 0.22 106.079 178.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 17.6 p80 -125.0 72.86 64.8 Favored Pre-proline 0 N--CA 1.45 -0.457 0 N-CA-C 108.667 -0.864 . . . . 0.46999999999999997 108.667 -178.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.457 ' HD3' HG22 ' A' ' 5' ' ' ILE . 60.0 Cg_endo -74.09 90.82 0.96 Allowed 'Trans proline' 0 N--CA 1.447 -1.214 0 C-N-CA 122.426 2.084 . . . . 0.80000000000000004 108.11 -179.104 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 14.7 t80 . . . . . 0 C--O 1.249 1.049 0 C-N-CA 125.728 1.611 . . . . 6.5199999999999996 108.34 171.502 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 . . . . . 0 N--CA 1.48 1.025 0 CA-C-O 120.592 0.234 . . . . 1.6799999999999999 111.437 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 23.5 ttm180 -95.23 48.48 1.17 Allowed 'General case' 0 C--O 1.226 -0.162 0 O-C-N 119.715 -1.866 . . . . 4.9800000000000004 108.874 -171.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 20.2 t -104.41 -26.12 3.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 C-N-CA 123.82 0.848 . . . . 0.23000000000000001 109.015 175.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 18.4 t80 -151.67 86.87 1.34 Allowed 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 107.853 -1.166 . . . . 1.78 107.853 -176.244 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.423 HG22 ' HD3' ' A' ' 7' ' ' PRO . 35.8 mm -116.67 130.71 71.07 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 N-CA-C 106.026 -1.842 . . . . 0.17999999999999999 106.026 178.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 21.5 p80 -121.15 81.65 36.81 Favored Pre-proline 0 N--CA 1.446 -0.67 0 N-CA-C 107.389 -1.337 . . . . 0.46000000000000002 107.389 178.035 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.423 ' HD3' HG22 ' A' ' 5' ' ' ILE . 84.1 Cg_endo -81.56 64.4 8.63 Favored 'Trans proline' 0 N--CA 1.451 -0.992 0 C-N-CA 122.191 1.927 . . . . 0.57999999999999996 108.45 178.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.084 0 CA-C-O 116.681 -1.628 . . . . 5.0999999999999996 108.207 -179.457 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 . . . . . 0 N--CA 1.48 1.053 0 N-CA-C 111.728 0.27 . . . . 1.72 111.728 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 20.8 ttm180 -93.37 49.1 1.36 Allowed 'General case' 0 C--O 1.226 -0.183 0 O-C-N 119.776 -1.827 . . . . 4.7699999999999996 108.786 -173.302 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 23.9 t -104.93 -26.49 3.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 C-N-CA 123.911 0.884 . . . . 0.22 109.124 174.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 20.4 t80 -151.03 87.55 1.41 Allowed 'General case' 0 N--CA 1.442 -0.861 0 N-CA-C 107.683 -1.229 . . . . 1.8500000000000001 107.683 -176.352 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.448 HG22 ' HD3' ' A' ' 7' ' ' PRO . 36.7 mm -117.15 131.07 70.94 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 N-CA-C 105.922 -1.881 . . . . 0.17999999999999999 105.922 178.615 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 22.8 p80 -121.49 82.55 40.09 Favored Pre-proline 0 N--CA 1.444 -0.735 0 N-CA-C 107.285 -1.376 . . . . 0.54000000000000004 107.285 177.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.448 ' HD3' HG22 ' A' ' 5' ' ' ILE . 97.0 Cg_endo -81.92 62.33 8.12 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 122.297 1.998 . . . . 0.58999999999999997 108.433 178.523 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.253 1.269 0 C-N-CA 126.01 1.724 . . . . 5.1399999999999997 108.042 -179.266 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 . . . . . 0 N--CA 1.479 1.005 0 N-CA-C 112.153 0.427 . . . . 1.6299999999999999 112.153 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 33.3 ttp180 -90.85 42.21 1.09 Allowed 'General case' 0 C--N 1.34 0.175 0 O-C-N 119.841 -1.787 . . . . 3.8599999999999999 110.44 -170.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 54.5 t -97.68 -28.88 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 C-N-CA 124.631 1.173 . . . . 0.42999999999999999 108.978 174.279 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 22.1 t80 -148.48 88.75 1.65 Allowed 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 108.883 -0.784 . . . . 1.78 108.883 -175.217 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 45.0 mm -120.44 135.69 59.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 N-CA-C 105.963 -1.866 . . . . 0.26000000000000001 105.963 179.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 15.2 p80 -127.72 74.41 78.34 Favored Pre-proline 0 N--CA 1.449 -0.517 0 N-CA-C 108.364 -0.976 . . . . 0.47999999999999998 108.364 -177.027 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -75.08 88.17 1.27 Allowed 'Trans proline' 0 N--CA 1.447 -1.214 0 C-N-CA 122.828 2.352 . . . . 0.76000000000000001 108.397 -176.342 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 45.9 t80 . . . . . 0 C--O 1.249 1.045 0 C-N-CA 125.473 1.509 . . . . 5.9400000000000004 108.246 171.462 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 . . . . . 0 N--CA 1.48 1.044 0 N-CA-C 113.17 0.804 . . . . 1.5800000000000001 113.17 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 24.8 ttp180 -90.14 43.04 1.12 Allowed 'General case' 0 C--N 1.342 0.252 0 O-C-N 119.701 -1.875 . . . . 3.75 110.663 -171.519 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 32.6 t -99.25 -28.11 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 C-N-CA 125.568 1.547 . . . . 0.32000000000000001 108.626 175.503 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 40.9 t80 -150.2 89.75 1.61 Allowed 'General case' 0 N--CA 1.442 -0.869 0 N-CA-C 107.983 -1.118 . . . . 1.8 107.983 -175.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.419 HG22 ' HD3' ' A' ' 7' ' ' PRO . 31.7 mm -119.24 138.28 50.43 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.459 0 N-CA-C 105.308 -2.108 . . . . 0.34000000000000002 105.308 176.679 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 15.6 p80 -127.68 73.72 78.35 Favored Pre-proline 0 N--CA 1.446 -0.658 0 N-CA-C 108.309 -0.997 . . . . 0.54000000000000004 108.309 -179.17 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.419 ' HD3' HG22 ' A' ' 5' ' ' ILE . 61.5 Cg_endo -72.63 94.75 0.78 Allowed 'Trans proline' 0 N--CA 1.447 -1.209 0 C-N-CA 121.646 1.564 . . . . 0.90000000000000002 108.771 -175.707 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 60.5 t80 . . . . . 0 C--O 1.253 1.28 0 CA-C-O 116.006 -1.95 . . . . 6.2699999999999996 106.751 171.313 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 . . . . . 0 N--CA 1.479 0.999 0 N-CA-C 112.204 0.446 . . . . 1.53 112.204 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 15.9 ttt180 -92.76 47.48 1.29 Allowed 'General case' 0 C--O 1.226 -0.173 0 O-C-N 119.958 -1.714 . . . . 3.8700000000000001 109.361 -172.437 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 23.5 t -103.59 -25.75 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 C-N-CA 123.992 0.917 . . . . 0.31 109.031 174.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 31.6 t80 -151.49 88.43 1.43 Allowed 'General case' 0 N--CA 1.44 -0.929 0 N-CA-C 107.854 -1.165 . . . . 2.27 107.854 -175.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.424 HG22 ' HD3' ' A' ' 7' ' ' PRO . 39.2 mm -119.12 133.42 66.0 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 N-CA-C 105.982 -1.859 . . . . 0.20999999999999999 105.982 179.316 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 15.0 p80 -124.8 73.8 63.98 Favored Pre-proline 0 N--CA 1.45 -0.464 0 N-CA-C 108.513 -0.921 . . . . 0.45000000000000001 108.513 -178.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.424 ' HD3' HG22 ' A' ' 5' ' ' ILE . 59.9 Cg_endo -74.29 89.72 1.05 Allowed 'Trans proline' 0 N--CA 1.447 -1.224 0 C-N-CA 122.415 2.076 . . . . 0.79000000000000004 108.144 -178.608 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 32.7 t80 . . . . . 0 C--O 1.249 1.031 0 C-N-CA 125.577 1.551 . . . . 5.9400000000000004 108.188 171.397 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 . . . . . 0 N--CA 1.477 0.924 0 CA-C-O 120.658 0.266 . . . . 1.5900000000000001 111.598 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 28.5 ttp180 -94.13 46.86 1.18 Allowed 'General case' 0 C--N 1.34 0.189 0 O-C-N 119.883 -1.761 . . . . 4.0599999999999996 109.48 -171.063 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 24.9 t -104.2 -27.2 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 C-N-CA 124.133 0.973 . . . . 0.22 109.171 176.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 24.6 t80 -150.29 87.5 1.46 Allowed 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 107.592 -1.262 . . . . 2.3500000000000001 107.592 -176.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.55 HG22 ' HD3' ' A' ' 7' ' ' PRO . 33.2 mm -116.56 131.94 67.67 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 N-CA-C 105.886 -1.894 . . . . 0.17000000000000001 105.886 177.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 23.3 p80 -121.58 81.96 40.27 Favored Pre-proline 0 N--CA 1.445 -0.696 0 N-CA-C 107.481 -1.303 . . . . 0.55000000000000004 107.481 176.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.55 ' HD3' HG22 ' A' ' 5' ' ' ILE . 85.3 Cg_endo -81.53 60.64 7.75 Favored 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 122.121 1.88 . . . . 0.65000000000000002 108.995 179.256 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.248 0.986 0 C-N-CA 126.264 1.826 . . . . 4.9699999999999998 108.049 -177.227 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 . . . . . 0 N--CA 1.48 1.033 0 N-CA-C 111.608 0.225 . . . . 1.78 111.608 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 25.6 ttm180 -93.48 48.4 1.3 Allowed 'General case' 0 C--O 1.225 -0.19 0 O-C-N 119.835 -1.791 . . . . 4.8600000000000003 109.016 -172.552 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 25.6 t -104.56 -26.76 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 C-N-CA 123.841 0.856 . . . . 0.25 109.198 175.136 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 32.4 t80 -150.8 87.28 1.41 Allowed 'General case' 0 N--CA 1.441 -0.91 0 N-CA-C 107.101 -1.444 . . . . 1.9199999999999999 107.101 -176.106 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.477 HG22 ' HD3' ' A' ' 7' ' ' PRO . 26.9 mm -115.64 132.65 64.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 105.205 -2.146 . . . . 0.20000000000000001 105.205 176.663 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 23.0 p80 -121.36 85.36 42.4 Favored Pre-proline 0 N--CA 1.442 -0.851 0 N-CA-C 107.028 -1.471 . . . . 0.56000000000000005 107.028 174.583 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.477 ' HD3' HG22 ' A' ' 5' ' ' ILE . 75.5 Cg_endo -81.42 58.69 6.99 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 122.079 1.852 . . . . 0.64000000000000001 108.761 176.252 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.254 1.297 0 C-N-CA 126.202 1.801 . . . . 5.21 107.711 -179.455 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 31.0 m-20 . . . . . 0 N--CA 1.479 1.014 0 N-CA-C 112.078 0.399 . . . . 1.53 112.078 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 3.2 ttp85 -92.82 44.65 1.16 Allowed 'General case' 0 C--N 1.339 0.124 0 O-C-N 119.897 -1.752 . . . . 4.4000000000000004 109.84 -171.066 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 24.2 t -101.89 -26.54 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 C-N-CA 123.917 0.887 . . . . 0.23000000000000001 108.939 176.41 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 27.9 t80 -150.99 87.48 1.41 Allowed 'General case' 0 N--CA 1.441 -0.911 0 N-CA-C 107.599 -1.26 . . . . 1.8100000000000001 107.599 -176.272 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.465 HG22 ' HD3' ' A' ' 7' ' ' PRO . 27.9 mm -115.87 133.25 62.89 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.514 0 N-CA-C 105.422 -2.066 . . . . 0.17999999999999999 105.422 176.814 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 21.0 p80 -121.67 83.2 41.87 Favored Pre-proline 0 N--CA 1.444 -0.743 0 N-CA-C 107.288 -1.375 . . . . 0.51000000000000001 107.288 175.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.465 ' HD3' HG22 ' A' ' 5' ' ' ILE . 94.2 Cg_endo -81.47 61.92 8.19 Favored 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 122.015 1.81 . . . . 0.59999999999999998 108.748 178.044 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.065 0 C-N-CA 126.252 1.821 . . . . 5.1100000000000003 108.133 -178.615 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 . . . . . 0 N--CA 1.48 1.037 0 CA-C-O 120.597 0.237 . . . . 1.8200000000000001 111.53 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 57.2 ttt180 -93.46 46.89 1.21 Allowed 'General case' 0 C--O 1.226 -0.18 0 O-C-N 119.735 -1.853 . . . . 3.9199999999999999 109.078 -171.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 16.0 t -103.95 -26.81 3.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 C-N-CA 124.17 0.988 . . . . 0.22 108.859 176.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -151.28 86.93 1.36 Allowed 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 107.415 -1.328 . . . . 1.8500000000000001 107.415 -176.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.51 HG22 ' HD3' ' A' ' 7' ' ' PRO . 28.2 mm -114.71 134.59 57.25 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.488 0 N-CA-C 105.423 -2.065 . . . . 0.17000000000000001 105.423 176.61 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 23.5 p80 -123.27 80.16 52.71 Favored Pre-proline 0 N--CA 1.444 -0.762 0 N-CA-C 107.564 -1.273 . . . . 0.55000000000000004 107.564 176.749 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.51 ' HD3' HG22 ' A' ' 5' ' ' ILE . 97.6 Cg_endo -80.84 65.87 8.88 Favored 'Trans proline' 0 N--CA 1.452 -0.954 0 C-N-CA 121.944 1.762 . . . . 0.57999999999999996 108.98 -179.566 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.022 0 C-N-CA 126.066 1.746 . . . . 5.0800000000000001 108.22 -178.291 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.478 0.936 0 CA-C-O 120.708 0.29 . . . . 1.8300000000000001 111.337 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 41.8 ttp180 -94.61 45.57 1.12 Allowed 'General case' 0 C--N 1.341 0.198 0 O-C-N 119.727 -1.858 . . . . 4.1799999999999997 109.476 -170.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 22.6 t -103.05 -27.4 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 C-N-CA 124.106 0.963 . . . . 0.20999999999999999 109.104 177.554 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 16.5 t80 -150.64 85.98 1.38 Allowed 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 107.356 -1.35 . . . . 2.3199999999999998 107.356 -176.208 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.535 HG22 ' HD3' ' A' ' 7' ' ' PRO . 27.7 mm -114.26 133.71 59.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 N-CA-C 105.62 -1.993 . . . . 0.16 105.62 176.772 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 22.1 p80 -122.12 79.88 43.41 Favored Pre-proline 0 N--CA 1.444 -0.743 0 N-CA-C 107.765 -1.198 . . . . 0.47999999999999998 107.765 176.126 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.535 ' HD3' HG22 ' A' ' 5' ' ' ILE . 73.4 Cg_endo -79.4 69.73 7.8 Favored 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 121.861 1.707 . . . . 0.51000000000000001 108.571 178.828 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.011 0 CA-C-O 116.821 -1.562 . . . . 5.0300000000000002 108.75 179.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 . . . . . 0 N--CA 1.479 1.016 0 N-CA-C 111.873 0.323 . . . . 1.6200000000000001 111.873 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 25.2 ttm180 -92.71 49.9 1.52 Allowed 'General case' 0 C--O 1.224 -0.259 0 O-C-N 119.842 -1.786 . . . . 4.8799999999999999 108.83 -173.243 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 42.9 t -103.89 -27.27 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 C-N-CA 123.876 0.87 . . . . 0.23999999999999999 109.112 172.302 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 15.7 t80 -150.07 87.06 1.45 Allowed 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 108.316 -0.994 . . . . 1.76 108.316 -175.773 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 39.8 mm -117.38 130.7 71.87 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 N-CA-C 106.012 -1.847 . . . . 0.17999999999999999 106.012 179.008 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 22.0 p80 -122.29 81.79 45.42 Favored Pre-proline 0 N--CA 1.446 -0.664 0 N-CA-C 107.249 -1.389 . . . . 0.47999999999999998 107.249 178.761 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -82.25 63.97 8.26 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 122.307 2.004 . . . . 0.58999999999999997 108.352 -179.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.254 1.302 0 C-N-CA 125.902 1.681 . . . . 5.0800000000000001 108.208 -178.7 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 . . . . . 0 N--CA 1.481 1.092 0 N-CA-C 113.127 0.788 . . . . 0.0 113.127 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 20.6 ttp180 -92.33 42.5 1.1 Allowed 'General case' 0 C--N 1.34 0.193 0 O-C-N 119.618 -1.926 . . . . 0.0 110.463 -168.051 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 38.5 t -97.43 -28.01 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 C-N-CA 125.49 1.516 . . . . 0.0 108.64 175.234 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 31.2 t80 -148.98 86.03 1.49 Allowed 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 -177.371 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.553 HG22 ' HD3' ' A' ' 7' ' ' PRO . 27.7 mm -114.04 136.05 51.78 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.484 0 N-CA-C 105.45 -2.056 . . . . 0.0 105.45 174.611 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 18.0 p80 -124.77 77.1 65.14 Favored Pre-proline 0 N--CA 1.443 -0.776 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 176.606 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.553 ' HD3' HG22 ' A' ' 5' ' ' ILE . 83.3 Cg_endo -74.77 86.39 1.39 Allowed 'Trans proline' 0 N--CA 1.45 -1.064 0 C-N-CA 121.612 1.541 . . . . 0.0 108.555 -175.634 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 2.7 t80 . . . . . 0 C--O 1.249 1.054 0 CA-C-O 117.405 -1.283 . . . . 0.0 107.751 177.433 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 . . . . . 0 N--CA 1.481 1.095 0 N-CA-C 113.109 0.781 . . . . 1.9399999999999999 113.109 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 15.2 ttp180 -97.12 46.12 1.04 Allowed 'General case' 0 C--N 1.341 0.224 0 O-C-N 119.475 -2.015 . . . . 4.0700000000000003 109.748 -170.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 24.7 t -98.77 -27.8 3.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 123.983 0.913 . . . . 0.33000000000000002 108.787 176.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 60.0 t80 -152.86 84.17 1.22 Allowed 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 108.781 -0.822 . . . . 1.8 108.781 -175.173 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.472 HG22 ' HD3' ' A' ' 7' ' ' PRO . 35.8 mm -114.99 128.47 72.13 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 N-CA-C 106.215 -1.772 . . . . 0.28000000000000003 106.215 179.198 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 21.5 p80 -121.91 80.99 42.15 Favored Pre-proline 0 N--CA 1.445 -0.68 0 N-CA-C 107.302 -1.37 . . . . 0.40999999999999998 107.302 178.113 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.472 ' HD3' HG22 ' A' ' 5' ' ' ILE . 89.8 Cg_endo -81.73 64.65 8.58 Favored 'Trans proline' 0 N--CA 1.451 -0.974 0 C-N-CA 122.211 1.941 . . . . 0.68000000000000005 108.244 179.379 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.023 0 C-N-CA 125.706 1.602 . . . . 5.2699999999999996 108.518 -178.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 . . . . . 0 N--CA 1.482 1.126 0 N-CA-C 112.945 0.72 . . . . 1.6100000000000001 112.945 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 2.2 ttt85 -98.17 47.78 1.0 Allowed 'General case' 0 C--O 1.225 -0.219 0 O-C-N 119.563 -1.961 . . . . 4.4400000000000004 108.978 -170.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 24.1 t -100.34 -26.89 3.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 108.945 -0.761 . . . . 0.23999999999999999 108.945 175.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 24.7 t80 -153.38 83.48 1.19 Allowed 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 108.644 -0.873 . . . . 1.8600000000000001 108.644 -175.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.626 HG22 ' HD3' ' A' ' 7' ' ' PRO . 31.7 mm -113.04 132.36 62.08 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 N-CA-C 105.977 -1.86 . . . . 0.20999999999999999 105.977 178.037 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 16.3 p80 -124.65 72.66 61.11 Favored Pre-proline 0 N--CA 1.447 -0.6 0 N-CA-C 108.626 -0.879 . . . . 0.67000000000000004 108.626 179.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.626 ' HD3' HG22 ' A' ' 5' ' ' ILE . 47.4 Cg_endo -72.48 90.58 0.79 Allowed 'Trans proline' 0 N--CA 1.45 -1.085 0 C-N-CA 121.762 1.641 . . . . 0.65000000000000002 108.709 -178.574 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 51.0 t80 . . . . . 0 C--O 1.252 1.206 0 CA-C-O 116.474 -1.726 . . . . 5.71 107.65 170.829 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 . . . . . 0 N--CA 1.483 1.194 0 N-CA-C 112.838 0.681 . . . . 2.0099999999999998 112.838 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 34.3 ttm180 -97.43 47.18 1.03 Allowed 'General case' 0 C--O 1.225 -0.228 0 O-C-N 119.708 -1.87 . . . . 5.0499999999999998 109.216 -170.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 20.3 t -100.07 -27.11 3.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 108.614 -0.884 . . . . 0.28999999999999998 108.614 175.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 43.7 t80 -153.25 84.17 1.2 Allowed 'General case' 0 N--CA 1.441 -0.911 0 N-CA-C 108.713 -0.847 . . . . 1.8200000000000001 108.713 -176.256 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.515 HG22 ' HD3' ' A' ' 7' ' ' PRO . 29.0 mm -112.87 132.24 62.21 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 N-CA-C 105.59 -2.004 . . . . 0.19 105.59 176.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 20.1 p80 -122.87 81.39 49.77 Favored Pre-proline 0 N--CA 1.444 -0.744 0 N-CA-C 107.215 -1.402 . . . . 0.40999999999999998 107.215 175.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.515 ' HD3' HG22 ' A' ' 5' ' ' ILE . 97.7 Cg_endo -80.91 66.13 8.86 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 121.878 1.719 . . . . 0.64000000000000001 108.42 178.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.023 0 CA-C-O 116.742 -1.599 . . . . 5.2699999999999996 108.513 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 . . . . . 0 N--CA 1.482 1.14 0 N-CA-C 112.754 0.65 . . . . 1.8400000000000001 112.754 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 7.5 ttp85 -97.51 45.69 1.03 Allowed 'General case' 0 C--N 1.34 0.163 0 O-C-N 119.686 -1.884 . . . . 4.5099999999999998 109.364 -170.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 21.1 t -98.94 -27.72 3.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 108.896 -0.779 . . . . 0.29999999999999999 108.896 176.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 38.4 t80 -152.98 83.35 1.21 Allowed 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 108.355 -0.979 . . . . 1.8100000000000001 108.355 -175.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.546 HG22 ' HD3' ' A' ' 7' ' ' PRO . 29.0 mm -112.14 131.42 63.62 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 N-CA-C 105.871 -1.9 . . . . 0.20000000000000001 105.871 177.238 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 21.0 p80 -122.38 78.96 45.37 Favored Pre-proline 0 N--CA 1.444 -0.737 0 N-CA-C 107.551 -1.278 . . . . 0.42999999999999999 107.551 176.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.546 ' HD3' HG22 ' A' ' 5' ' ' ILE . 73.4 Cg_endo -79.69 70.11 7.65 Favored 'Trans proline' 0 N--CA 1.45 -1.029 0 C-N-CA 121.832 1.688 . . . . 0.58999999999999997 108.537 179.498 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.252 1.212 0 CA-C-O 116.93 -1.51 . . . . 5.1399999999999997 108.635 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 . . . . . 0 N--CA 1.483 1.177 0 N-CA-C 114.165 1.172 . . . . 1.9099999999999999 114.165 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 53.1 ttp180 -96.15 51.44 1.22 Allowed 'General case' 0 C--O 1.227 -0.117 0 O-C-N 119.724 -1.86 . . . . 4.04 109.253 -171.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 38.8 t -102.81 -27.53 3.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 124.391 1.077 . . . . 0.25 108.777 173.172 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 85.6 t80 -152.78 86.26 1.26 Allowed 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 108.893 -0.78 . . . . 2.6400000000000001 108.893 -174.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.479 HG22 ' HD3' ' A' ' 7' ' ' PRO . 40.6 mm -118.75 131.88 70.25 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 N-CA-C 106.031 -1.84 . . . . 0.22 106.031 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 13.5 p80 -125.71 73.15 69.26 Favored Pre-proline 0 N--CA 1.448 -0.527 0 N-CA-C 108.527 -0.916 . . . . 0.65000000000000002 108.527 -178.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.479 ' HD3' HG22 ' A' ' 5' ' ' ILE . 71.4 Cg_endo -74.72 90.23 1.07 Allowed 'Trans proline' 0 N--CA 1.446 -1.296 0 C-N-CA 122.492 2.128 . . . . 0.67000000000000004 107.963 -177.723 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 37.7 t80 . . . . . 0 C--O 1.25 1.112 0 C-N-CA 125.661 1.584 . . . . 5.7599999999999998 108.361 172.766 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 . . . . . 0 N--CA 1.481 1.104 0 N-CA-C 113.08 0.77 . . . . 2.0699999999999998 113.08 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 22.2 ttm180 -99.21 48.54 0.95 Allowed 'General case' 0 C--N 1.341 0.203 0 O-C-N 119.602 -1.937 . . . . 5.0499999999999998 108.978 -170.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.1 t -100.01 -26.87 3.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 108.962 -0.755 . . . . 0.23000000000000001 108.962 175.283 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 57.2 t80 -153.5 84.42 1.18 Allowed 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 108.717 -0.846 . . . . 2.6299999999999999 108.717 -174.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.499 HG22 ' HD3' ' A' ' 7' ' ' PRO . 36.1 mm -115.91 130.61 70.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 N-CA-C 106.2 -1.778 . . . . 0.26000000000000001 106.2 179.6 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 14.8 p80 -124.69 73.44 62.61 Favored Pre-proline 0 N--CA 1.449 -0.499 0 N-CA-C 108.469 -0.937 . . . . 0.73999999999999999 108.469 -178.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.499 ' HD3' HG22 ' A' ' 5' ' ' ILE . 57.9 Cg_endo -74.7 88.49 1.19 Allowed 'Trans proline' 0 N--CA 1.447 -1.214 0 C-N-CA 122.171 1.914 . . . . 0.62 108.118 -178.501 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 23.4 t80 . . . . . 0 C--O 1.25 1.087 0 C-N-CA 125.688 1.595 . . . . 6.04 108.002 171.717 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 . . . . . 0 N--CA 1.482 1.129 0 N-CA-C 112.85 0.685 . . . . 1.9099999999999999 112.85 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 24.9 ttp-105 -96.76 47.97 1.06 Allowed 'General case' 0 CA--C 1.521 -0.146 0 O-C-N 119.636 -1.915 . . . . 4.5300000000000002 109.178 -169.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 43.7 t -99.57 -26.82 3.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 108.709 -0.849 . . . . 0.31 108.709 173.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 33.0 t80 -152.8 85.07 1.23 Allowed 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 108.99 -0.745 . . . . 2.6899999999999999 108.99 -175.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.494 HG22 ' HD3' ' A' ' 7' ' ' PRO . 30.6 mm -113.77 135.55 53.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 N-CA-C 105.517 -2.031 . . . . 0.20999999999999999 105.517 177.131 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 12.5 p80 -126.58 73.4 74.29 Favored Pre-proline 0 N--CA 1.447 -0.612 0 N-CA-C 108.3 -1.0 . . . . 0.66000000000000003 108.3 179.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.494 ' HD3' HG22 ' A' ' 5' ' ' ILE . 61.1 Cg_endo -73.67 91.08 0.9 Allowed 'Trans proline' 0 N--CA 1.448 -1.167 0 C-N-CA 122.292 1.995 . . . . 0.69999999999999996 108.16 -178.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 25.5 t80 . . . . . 0 C--O 1.249 1.066 0 C-N-CA 125.8 1.64 . . . . 6.3600000000000003 108.332 172.307 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 . . . . . 0 N--CA 1.48 1.062 0 N-CA-C 112.265 0.469 . . . . 1.8200000000000001 112.265 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 5.0 ttm180 -95.74 46.2 1.09 Allowed 'General case' 0 C--O 1.225 -0.207 0 O-C-N 119.68 -1.887 . . . . 4.7199999999999998 109.37 -171.036 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 22.3 t -99.98 -26.72 3.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 123.654 0.781 . . . . 0.29999999999999999 108.927 176.206 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 48.0 t80 -152.64 85.86 1.26 Allowed 'General case' 0 N--CA 1.441 -0.911 0 N-CA-C 107.763 -1.199 . . . . 2.1000000000000001 107.763 -175.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.546 HG22 ' HD3' ' A' ' 7' ' ' PRO . 28.8 mm -114.73 130.74 68.62 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.502 0 N-CA-C 105.532 -2.025 . . . . 0.20000000000000001 105.532 177.128 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 21.9 p80 -122.35 81.33 45.74 Favored Pre-proline 0 N--CA 1.443 -0.807 0 N-CA-C 107.382 -1.34 . . . . 0.40000000000000002 107.382 175.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.546 ' HD3' HG22 ' A' ' 5' ' ' ILE . 72.0 Cg_endo -80.94 65.0 8.96 Favored 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 121.796 1.664 . . . . 0.64000000000000001 108.518 178.258 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.254 1.306 0 C-N-CA 125.78 1.632 . . . . 5.0700000000000003 108.222 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 31.9 m-20 . . . . . 0 N--CA 1.479 0.998 0 N-CA-C 112.299 0.481 . . . . 1.8 112.299 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 41.1 ttp85 -93.76 44.01 1.12 Allowed 'General case' 0 C--N 1.341 0.215 0 O-C-N 119.788 -1.82 . . . . 4.1399999999999997 109.859 -171.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 22.2 t -101.29 -27.3 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 C-N-CA 124.153 0.981 . . . . 0.28000000000000003 108.882 177.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 15.3 t80 -150.97 87.84 1.43 Allowed 'General case' 0 N--CA 1.443 -0.821 0 N-CA-C 107.915 -1.142 . . . . 1.78 107.915 -176.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.457 HG22 ' HD3' ' A' ' 7' ' ' PRO . 37.6 mm -117.76 134.03 62.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 106.079 -1.822 . . . . 0.22 106.079 178.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 17.6 p80 -125.0 72.86 64.8 Favored Pre-proline 0 N--CA 1.45 -0.457 0 N-CA-C 108.667 -0.864 . . . . 0.46999999999999997 108.667 -178.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.457 ' HD3' HG22 ' A' ' 5' ' ' ILE . 60.0 Cg_endo -74.09 90.82 0.96 Allowed 'Trans proline' 0 N--CA 1.447 -1.214 0 C-N-CA 122.426 2.084 . . . . 0.80000000000000004 108.11 -179.104 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 14.7 t80 . . . . . 0 C--O 1.249 1.049 0 C-N-CA 125.728 1.611 . . . . 6.5199999999999996 108.34 171.502 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 . . . . . 0 N--CA 1.48 1.025 0 CA-C-O 120.592 0.234 . . . . 1.6799999999999999 111.437 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 23.5 ttm180 -95.23 48.48 1.17 Allowed 'General case' 0 C--O 1.226 -0.162 0 O-C-N 119.715 -1.866 . . . . 4.9800000000000004 108.874 -171.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 20.2 t -104.41 -26.12 3.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 C-N-CA 123.82 0.848 . . . . 0.23000000000000001 109.015 175.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 18.4 t80 -151.67 86.87 1.34 Allowed 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 107.853 -1.166 . . . . 1.78 107.853 -176.244 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.423 HG22 ' HD3' ' A' ' 7' ' ' PRO . 35.8 mm -116.67 130.71 71.07 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 N-CA-C 106.026 -1.842 . . . . 0.17999999999999999 106.026 178.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 21.5 p80 -121.15 81.65 36.81 Favored Pre-proline 0 N--CA 1.446 -0.67 0 N-CA-C 107.389 -1.337 . . . . 0.46000000000000002 107.389 178.035 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.423 ' HD3' HG22 ' A' ' 5' ' ' ILE . 84.1 Cg_endo -81.56 64.4 8.63 Favored 'Trans proline' 0 N--CA 1.451 -0.992 0 C-N-CA 122.191 1.927 . . . . 0.57999999999999996 108.45 178.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.084 0 CA-C-O 116.681 -1.628 . . . . 5.0999999999999996 108.207 -179.457 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 . . . . . 0 N--CA 1.48 1.053 0 N-CA-C 111.728 0.27 . . . . 1.72 111.728 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 20.8 ttm180 -93.37 49.1 1.36 Allowed 'General case' 0 C--O 1.226 -0.183 0 O-C-N 119.776 -1.827 . . . . 4.7699999999999996 108.786 -173.302 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 23.9 t -104.93 -26.49 3.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 C-N-CA 123.911 0.884 . . . . 0.22 109.124 174.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 20.4 t80 -151.03 87.55 1.41 Allowed 'General case' 0 N--CA 1.442 -0.861 0 N-CA-C 107.683 -1.229 . . . . 1.8500000000000001 107.683 -176.352 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.448 HG22 ' HD3' ' A' ' 7' ' ' PRO . 36.7 mm -117.15 131.07 70.94 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 N-CA-C 105.922 -1.881 . . . . 0.17999999999999999 105.922 178.615 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 22.8 p80 -121.49 82.55 40.09 Favored Pre-proline 0 N--CA 1.444 -0.735 0 N-CA-C 107.285 -1.376 . . . . 0.54000000000000004 107.285 177.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.448 ' HD3' HG22 ' A' ' 5' ' ' ILE . 97.0 Cg_endo -81.92 62.33 8.12 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 122.297 1.998 . . . . 0.58999999999999997 108.433 178.523 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.253 1.269 0 C-N-CA 126.01 1.724 . . . . 5.1399999999999997 108.042 -179.266 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 . . . . . 0 N--CA 1.479 1.005 0 N-CA-C 112.153 0.427 . . . . 1.6299999999999999 112.153 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 33.3 ttp180 -90.85 42.21 1.09 Allowed 'General case' 0 C--N 1.34 0.175 0 O-C-N 119.841 -1.787 . . . . 3.8599999999999999 110.44 -170.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 54.5 t -97.68 -28.88 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 C-N-CA 124.631 1.173 . . . . 0.42999999999999999 108.978 174.279 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 22.1 t80 -148.48 88.75 1.65 Allowed 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 108.883 -0.784 . . . . 1.78 108.883 -175.217 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 45.0 mm -120.44 135.69 59.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 N-CA-C 105.963 -1.866 . . . . 0.26000000000000001 105.963 179.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 15.2 p80 -127.72 74.41 78.34 Favored Pre-proline 0 N--CA 1.449 -0.517 0 N-CA-C 108.364 -0.976 . . . . 0.47999999999999998 108.364 -177.027 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -75.08 88.17 1.27 Allowed 'Trans proline' 0 N--CA 1.447 -1.214 0 C-N-CA 122.828 2.352 . . . . 0.76000000000000001 108.397 -176.342 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 45.9 t80 . . . . . 0 C--O 1.249 1.045 0 C-N-CA 125.473 1.509 . . . . 5.9400000000000004 108.246 171.462 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 . . . . . 0 N--CA 1.48 1.044 0 N-CA-C 113.17 0.804 . . . . 1.5800000000000001 113.17 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 24.8 ttp180 -90.14 43.04 1.12 Allowed 'General case' 0 C--N 1.342 0.252 0 O-C-N 119.701 -1.875 . . . . 3.75 110.663 -171.519 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 32.6 t -99.25 -28.11 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 C-N-CA 125.568 1.547 . . . . 0.32000000000000001 108.626 175.503 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 40.9 t80 -150.2 89.75 1.61 Allowed 'General case' 0 N--CA 1.442 -0.869 0 N-CA-C 107.983 -1.118 . . . . 1.8 107.983 -175.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.419 HG22 ' HD3' ' A' ' 7' ' ' PRO . 31.7 mm -119.24 138.28 50.43 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.459 0 N-CA-C 105.308 -2.108 . . . . 0.34000000000000002 105.308 176.679 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 15.6 p80 -127.68 73.72 78.35 Favored Pre-proline 0 N--CA 1.446 -0.658 0 N-CA-C 108.309 -0.997 . . . . 0.54000000000000004 108.309 -179.17 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.419 ' HD3' HG22 ' A' ' 5' ' ' ILE . 61.5 Cg_endo -72.63 94.75 0.78 Allowed 'Trans proline' 0 N--CA 1.447 -1.209 0 C-N-CA 121.646 1.564 . . . . 0.90000000000000002 108.771 -175.707 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 60.5 t80 . . . . . 0 C--O 1.253 1.28 0 CA-C-O 116.006 -1.95 . . . . 6.2699999999999996 106.751 171.313 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 . . . . . 0 N--CA 1.479 0.999 0 N-CA-C 112.204 0.446 . . . . 1.53 112.204 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 15.9 ttt180 -92.76 47.48 1.29 Allowed 'General case' 0 C--O 1.226 -0.173 0 O-C-N 119.958 -1.714 . . . . 3.8700000000000001 109.361 -172.437 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 23.5 t -103.59 -25.75 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 C-N-CA 123.992 0.917 . . . . 0.31 109.031 174.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 31.6 t80 -151.49 88.43 1.43 Allowed 'General case' 0 N--CA 1.44 -0.929 0 N-CA-C 107.854 -1.165 . . . . 2.27 107.854 -175.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.424 HG22 ' HD3' ' A' ' 7' ' ' PRO . 39.2 mm -119.12 133.42 66.0 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 N-CA-C 105.982 -1.859 . . . . 0.20999999999999999 105.982 179.316 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 15.0 p80 -124.8 73.8 63.98 Favored Pre-proline 0 N--CA 1.45 -0.464 0 N-CA-C 108.513 -0.921 . . . . 0.45000000000000001 108.513 -178.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.424 ' HD3' HG22 ' A' ' 5' ' ' ILE . 59.9 Cg_endo -74.29 89.72 1.05 Allowed 'Trans proline' 0 N--CA 1.447 -1.224 0 C-N-CA 122.415 2.076 . . . . 0.79000000000000004 108.144 -178.608 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 32.7 t80 . . . . . 0 C--O 1.249 1.031 0 C-N-CA 125.577 1.551 . . . . 5.9400000000000004 108.188 171.397 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 . . . . . 0 N--CA 1.477 0.924 0 CA-C-O 120.658 0.266 . . . . 1.5900000000000001 111.598 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 28.5 ttp180 -94.13 46.86 1.18 Allowed 'General case' 0 C--N 1.34 0.189 0 O-C-N 119.883 -1.761 . . . . 4.0599999999999996 109.48 -171.063 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 24.9 t -104.2 -27.2 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 C-N-CA 124.133 0.973 . . . . 0.22 109.171 176.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 24.6 t80 -150.29 87.5 1.46 Allowed 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 107.592 -1.262 . . . . 2.3500000000000001 107.592 -176.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.55 HG22 ' HD3' ' A' ' 7' ' ' PRO . 33.2 mm -116.56 131.94 67.67 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 N-CA-C 105.886 -1.894 . . . . 0.17000000000000001 105.886 177.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 23.3 p80 -121.58 81.96 40.27 Favored Pre-proline 0 N--CA 1.445 -0.696 0 N-CA-C 107.481 -1.303 . . . . 0.55000000000000004 107.481 176.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.55 ' HD3' HG22 ' A' ' 5' ' ' ILE . 85.3 Cg_endo -81.53 60.64 7.75 Favored 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 122.121 1.88 . . . . 0.65000000000000002 108.995 179.256 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.248 0.986 0 C-N-CA 126.264 1.826 . . . . 4.9699999999999998 108.049 -177.227 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 . . . . . 0 N--CA 1.48 1.033 0 N-CA-C 111.608 0.225 . . . . 1.78 111.608 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 25.6 ttm180 -93.48 48.4 1.3 Allowed 'General case' 0 C--O 1.225 -0.19 0 O-C-N 119.835 -1.791 . . . . 4.8600000000000003 109.016 -172.552 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 25.6 t -104.56 -26.76 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 C-N-CA 123.841 0.856 . . . . 0.25 109.198 175.136 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 32.4 t80 -150.8 87.28 1.41 Allowed 'General case' 0 N--CA 1.441 -0.91 0 N-CA-C 107.101 -1.444 . . . . 1.9199999999999999 107.101 -176.106 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.477 HG22 ' HD3' ' A' ' 7' ' ' PRO . 26.9 mm -115.64 132.65 64.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 105.205 -2.146 . . . . 0.20000000000000001 105.205 176.663 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 23.0 p80 -121.36 85.36 42.4 Favored Pre-proline 0 N--CA 1.442 -0.851 0 N-CA-C 107.028 -1.471 . . . . 0.56000000000000005 107.028 174.583 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.477 ' HD3' HG22 ' A' ' 5' ' ' ILE . 75.5 Cg_endo -81.42 58.69 6.99 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 122.079 1.852 . . . . 0.64000000000000001 108.761 176.252 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.254 1.297 0 C-N-CA 126.202 1.801 . . . . 5.21 107.711 -179.455 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 31.0 m-20 . . . . . 0 N--CA 1.479 1.014 0 N-CA-C 112.078 0.399 . . . . 1.53 112.078 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 3.2 ttp85 -92.82 44.65 1.16 Allowed 'General case' 0 C--N 1.339 0.124 0 O-C-N 119.897 -1.752 . . . . 4.4000000000000004 109.84 -171.066 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 24.2 t -101.89 -26.54 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 C-N-CA 123.917 0.887 . . . . 0.23000000000000001 108.939 176.41 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 27.9 t80 -150.99 87.48 1.41 Allowed 'General case' 0 N--CA 1.441 -0.911 0 N-CA-C 107.599 -1.26 . . . . 1.8100000000000001 107.599 -176.272 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.465 HG22 ' HD3' ' A' ' 7' ' ' PRO . 27.9 mm -115.87 133.25 62.89 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.514 0 N-CA-C 105.422 -2.066 . . . . 0.17999999999999999 105.422 176.814 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 21.0 p80 -121.67 83.2 41.87 Favored Pre-proline 0 N--CA 1.444 -0.743 0 N-CA-C 107.288 -1.375 . . . . 0.51000000000000001 107.288 175.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.465 ' HD3' HG22 ' A' ' 5' ' ' ILE . 94.2 Cg_endo -81.47 61.92 8.19 Favored 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 122.015 1.81 . . . . 0.59999999999999998 108.748 178.044 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.065 0 C-N-CA 126.252 1.821 . . . . 5.1100000000000003 108.133 -178.615 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 . . . . . 0 N--CA 1.48 1.037 0 CA-C-O 120.597 0.237 . . . . 1.8200000000000001 111.53 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 57.2 ttt180 -93.46 46.89 1.21 Allowed 'General case' 0 C--O 1.226 -0.18 0 O-C-N 119.735 -1.853 . . . . 3.9199999999999999 109.078 -171.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 16.0 t -103.95 -26.81 3.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 C-N-CA 124.17 0.988 . . . . 0.22 108.859 176.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -151.28 86.93 1.36 Allowed 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 107.415 -1.328 . . . . 1.8500000000000001 107.415 -176.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.51 HG22 ' HD3' ' A' ' 7' ' ' PRO . 28.2 mm -114.71 134.59 57.25 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.488 0 N-CA-C 105.423 -2.065 . . . . 0.17000000000000001 105.423 176.61 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 23.5 p80 -123.27 80.16 52.71 Favored Pre-proline 0 N--CA 1.444 -0.762 0 N-CA-C 107.564 -1.273 . . . . 0.55000000000000004 107.564 176.749 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.51 ' HD3' HG22 ' A' ' 5' ' ' ILE . 97.6 Cg_endo -80.84 65.87 8.88 Favored 'Trans proline' 0 N--CA 1.452 -0.954 0 C-N-CA 121.944 1.762 . . . . 0.57999999999999996 108.98 -179.566 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.022 0 C-N-CA 126.066 1.746 . . . . 5.0800000000000001 108.22 -178.291 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.478 0.936 0 CA-C-O 120.708 0.29 . . . . 1.8300000000000001 111.337 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 41.8 ttp180 -94.61 45.57 1.12 Allowed 'General case' 0 C--N 1.341 0.198 0 O-C-N 119.727 -1.858 . . . . 4.1799999999999997 109.476 -170.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 22.6 t -103.05 -27.4 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 C-N-CA 124.106 0.963 . . . . 0.20999999999999999 109.104 177.554 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 16.5 t80 -150.64 85.98 1.38 Allowed 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 107.356 -1.35 . . . . 2.3199999999999998 107.356 -176.208 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.535 HG22 ' HD3' ' A' ' 7' ' ' PRO . 27.7 mm -114.26 133.71 59.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 N-CA-C 105.62 -1.993 . . . . 0.16 105.62 176.772 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 22.1 p80 -122.12 79.88 43.41 Favored Pre-proline 0 N--CA 1.444 -0.743 0 N-CA-C 107.765 -1.198 . . . . 0.47999999999999998 107.765 176.126 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.535 ' HD3' HG22 ' A' ' 5' ' ' ILE . 73.4 Cg_endo -79.4 69.73 7.8 Favored 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 121.861 1.707 . . . . 0.51000000000000001 108.571 178.828 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.011 0 CA-C-O 116.821 -1.562 . . . . 5.0300000000000002 108.75 179.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 . . . . . 0 N--CA 1.479 1.016 0 N-CA-C 111.873 0.323 . . . . 1.6200000000000001 111.873 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 25.2 ttm180 -92.71 49.9 1.52 Allowed 'General case' 0 C--O 1.224 -0.259 0 O-C-N 119.842 -1.786 . . . . 4.8799999999999999 108.83 -173.243 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 42.9 t -103.89 -27.27 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 C-N-CA 123.876 0.87 . . . . 0.23999999999999999 109.112 172.302 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 15.7 t80 -150.07 87.06 1.45 Allowed 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 108.316 -0.994 . . . . 1.76 108.316 -175.773 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 39.8 mm -117.38 130.7 71.87 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 N-CA-C 106.012 -1.847 . . . . 0.17999999999999999 106.012 179.008 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 22.0 p80 -122.29 81.79 45.42 Favored Pre-proline 0 N--CA 1.446 -0.664 0 N-CA-C 107.249 -1.389 . . . . 0.47999999999999998 107.249 178.761 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -82.25 63.97 8.26 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 122.307 2.004 . . . . 0.58999999999999997 108.352 -179.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.254 1.302 0 C-N-CA 125.902 1.681 . . . . 5.0800000000000001 108.208 -178.7 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 . . . . . 0 N--CA 1.481 1.092 0 N-CA-C 113.127 0.788 . . . . 0.0 113.127 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 20.6 ttp180 -92.33 42.5 1.1 Allowed 'General case' 0 C--N 1.34 0.193 0 O-C-N 119.618 -1.926 . . . . 0.0 110.463 -168.051 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 38.5 t -97.43 -28.01 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 C-N-CA 125.49 1.516 . . . . 0.0 108.64 175.234 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 31.2 t80 -148.98 86.03 1.49 Allowed 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 -177.371 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.553 HG22 ' HD3' ' A' ' 7' ' ' PRO . 27.7 mm -114.04 136.05 51.78 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.484 0 N-CA-C 105.45 -2.056 . . . . 0.0 105.45 174.611 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 18.0 p80 -124.77 77.1 65.14 Favored Pre-proline 0 N--CA 1.443 -0.776 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 176.606 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.553 ' HD3' HG22 ' A' ' 5' ' ' ILE . 83.3 Cg_endo -74.77 86.39 1.39 Allowed 'Trans proline' 0 N--CA 1.45 -1.064 0 C-N-CA 121.612 1.541 . . . . 0.0 108.555 -175.634 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 2.7 t80 . . . . . 0 C--O 1.249 1.054 0 CA-C-O 117.405 -1.283 . . . . 0.0 107.751 177.433 . . . . . . . . 0 0 . 1 stop_ save_